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Abstract
Articular cartilage injury and progressive degeneration, combined with the clinical needs that result from
an aging population and increasing rates of diagnosed osteoarthritis, have created a burgeoning demand
for therapies aimed at cartilage repair. One approach that has gained traction is the delivery of clinically
relevant cell types such as mesenchymal stromal cells to the injury site using hydrogels, which are waterswollen polymer networks that can be engineered to suit a wide variety of applications. Previous insights
have led us to identify the roles of parameters such as cellular density, matrix degradation, mechanical
loading, and even cell-cell communication in engineered cartilage formation and maturation. These
hydrogels often employ biomaterials such as hyaluronic acid that are native to the body and intended to
influence cell behavior. However, hydrogel-based therapies to date have predominantly focused on
permitting or facilitating the eventual maturation of cartilage tissue by enabling matrix remodeling and
distribution; meanwhile, the need for materials with controlled and timely presentation of cues that are
essential for correct initial lineage commitment and early differentiation by cells has often been
overlooked.
This dissertation describes the design and characterization of hyaluronic acid hydrogels that incorporate
developmentally relevant and tunable cell-matrix and cell-cell cues that are critical in the early lineage
commitment and differentiation of mesenchymal stromal cells. In particular, emphasis is given to the
presentation of such cues over time at the cell-hydrogel interface, where cells encapsulated in these
hydrogels actively interact with and even contribute to their microenvironments.
First, we examine tunable cell-matrix interactions in hydrogels by demonstrating that the biological
activity of cell-laden hydrogels formed using crosslinkable modified hyaluronic acid, which provides cellmatrix cues relevant to cartilage development, may be altered as a function of the extent, type, and
location of macromer modification. In both early gene expression and long-term in vitro culture, we show
that this can alter mesenchymal stromal cell differentiation and subsequent construct maturation.
Building on this, we explore a hyaluronic acid-based hydrogel with additional tunable cell-cell interaction
mimicry via N-Cadherin mimetic peptides. We demonstrate the ability of this cue to also enhance both
early differentiation and long-term neotissue formation by cells in a dose- and timing-dependent manner,
where higher concentrations further promote the maturation of the engineered construct as long as the
signal is stably presented to influence cell behavior during early timepoints. Finally, we examine the
spatial deposition of pericellular matrix at the cell-hydrogel interface using live-cell metabolic labeling to
determine when, and for how long, the cues that are engineered into hydrogels may in fact be presented
to cells. We show that cells may physically displace the hydrogel from their microenvironment as they
begin to synthesize and deposit pericellular matrix, and that this can occur as soon as 3 days after
encapsulation, with important implications for hydrogel design towards cartilage tissue engineering
applications.
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ABSTRACT
ENGINEERING THE INTERFACE: HYALURONIC ACID HYDROGELS THAT MEDIATE MSC
CHONDROGENESIS FOR CARTILAGE TISSUE ENGINEERING

Mi Y. Kwon
Jason A. Burdick, Ph.D.

Articular cartilage injury and progressive degeneration, combined with the clinical
needs that result from an aging population and increasing rates of diagnosed
osteoarthritis, have created a burgeoning demand for therapies aimed at cartilage repair.
One approach that has gained traction is the delivery of clinically relevant cell types such
as mesenchymal stromal cells to the injury site using hydrogels, which are water-swollen
polymer networks that can be engineered to suit a wide variety of applications. Previous
insights have led us to identify the roles of parameters such as cellular density, matrix
degradation, mechanical loading, and even cell-cell communication in engineered
cartilage formation and maturation. These hydrogels often employ biomaterials such as
hyaluronic acid that are native to the body and intended to influence cell behavior.
However, hydrogel-based therapies to date have predominantly focused on permitting or
facilitating the eventual maturation of cartilage tissue by enabling matrix remodeling and
distribution; meanwhile, the need for materials with controlled and timely presentation of
cues that are essential for correct initial lineage commitment and early differentiation by
cells has often been overlooked.
This dissertation describes the design and characterization of hyaluronic acid
hydrogels that incorporate developmentally relevant and tunable cell-matrix and cell-cell
iii

cues that are critical in the early lineage commitment and differentiation of mesenchymal
stromal cells. In particular, emphasis is given to the presentation of such cues over time
at the cell-hydrogel interface, where cells encapsulated in these hydrogels actively
interact with and even contribute to their microenvironments.
First, we examine tunable cell-matrix interactions in hydrogels by demonstrating
that the biological activity of cell-laden hydrogels formed using crosslinkable modified
hyaluronic acid, which provides cell-matrix cues relevant to cartilage development, may
be altered as a function of the extent, type, and location of macromer modification. In
both early gene expression and long-term in vitro culture, we show that this can alter
mesenchymal stromal cell differentiation and subsequent construct maturation. Building
on this, we explore a hyaluronic acid-based hydrogel with additional tunable cell-cell
interaction mimicry via N-Cadherin mimetic peptides. We demonstrate the ability of this
cue to also enhance both early differentiation and long-term neotissue formation by cells
in a dose- and timing-dependent manner, where higher concentrations further promote
the maturation of the engineered construct as long as the signal is stably presented to
influence cell behavior during early timepoints. Finally, we examine the spatial deposition
of pericellular matrix at the cell-hydrogel interface using live-cell metabolic labeling to
determine when, and for how long, the cues that are engineered into hydrogels may in
fact be presented to cells. We show that cells may physically displace the hydrogel from
their microenvironment as they begin to synthesize and deposit pericellular matrix, and
that this can occur as soon as 3 days after encapsulation, with important implications for
hydrogel design towards cartilage tissue engineering applications.
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CHAPTER 1

INTRODUCTION

1.1. SIGNIFICANCE
Articular cartilage injury and subsequent degeneration is cited as the most
frequent cause of disability among adults in the US, with up to 53 million adults reporting
doctor-diagnosed arthritis and nearly 23 million adults reporting limitations in activity due
to cartilage degeneration.1 Articular cartilage is a connective tissue that lines surfaces at
the ends of long bones to enable smooth movement, but it exhibits poor inherent
regenerative capacity due to its avascularity, alymphaticity, and a sparse native cell
population consisting of chondrocytes with no neuronal connections.1,2 Normal articular
cartilage exhibits three major zones of matrix and cell organization; damage due to injury
typically begins as a focal defect in the superficial and/or middle zones, which later
progresses to a full-thickness defect through the subchondral bone marked by
histological changes to all zones of the tissue (Figure 1.1).1
There are numerous clinical treatment options for patients with articular cartilage
damage, such as microfracture, cartilage grafting, autologous chondrocyte implantation
(ACI), and matrix-assisted autologous chondrocyte implantation (MACI); however, each
of these therapies has inherent limitations.3-6 In particular, despite some promising
results and improvements in recent years, the formed cartilage from these clinical
interventions is still markedly inferior to native articular cartilage in both biochemical
content and mechanical properties, and it often degrades over a period of months to
years. Collectively, although some marked progress has been made, the clinical
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interventions that are currently available do not fully address the need for stable cartilage
tissue repair.

Figure 1.1. Structure and compartmental organization of articular cartilage in
diarthrodial joints. Articular cartilage lines the surfaces of long bones and is
surrounded by synovial fluid that is encapsulated within a synovial membrane (a).
Cartilage tissue consists of chondrocytes within several layers of extracellular matrix,
including superficial, middle, and deep zones, with a histologically visible tidemark
marking the calcified region and subchondral bone (b, c). Damage and subsequent
degradation of the tissue results in histological changes such as fissuring and
fragmentation, and vascular invasion of the calcified region (d). Adapted from MartelPelletier et al.7
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1.2. CURRENT CLINICAL APPROACHES TO CARTILAGE REPAIR
Strategies to repair cartilage defects began with early surgical procedures that
aimed to induce or encourage endogenous repair mechanisms, such as in the case of
microfracture, where the subchondral bone is punctured to release progenitor cells and
blood into the defect.8 The FDA and many clinicians consider microfracture to be the
gold standard for cartilage repair to date, but prospective comparative studies now
show that microfracture may only delay cartilage degeneration in the short-term more than 5 years after surgery, treatment failure is expected regardless of the size of
the cartilage lesion.9-10 While microfracture continues to be a ubiquitous approach to
surgical repair of cartilage, its shortcomings have ultimately encouraged the
development of novel procedures that aim to achieve more robust repair (Figure
1.2).11

Figure 1.2. Clinically available techniques for cartilage repair. A full-thickness
cartilage defect (a) is first debrided (b) to leave only healthy and stable tissue margins
that encourage tissue integration. From here, a number of approaches can be used: (c)
microfracture can release blood and progenitors from the underlying subchondral bone,
(d) ACI can introduce and seal autologous chondrocytes into the defect site, or (e) MACI
can provide a 3D scaffold along with autologous cells to encourage tissue formation.
Adapted from Makris et al.13
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Approaches that were further developed involved both grafting of autologous
tissue (i.e., autologous osteochondral transplantation or mosaicplasty) that is
harvested from a healthy tissue site, and, more recently, cell-based therapies such as
ACI.3,4,12 ACI is a procedure in which a patient’s own chondrocytes are implanted into a
debrided lesion in the host tissue. To perform this technique, a full-thickness sample
from a low-weight-bearing region of the joint is harvested via biopsy punch during a
first arthroscopic procedure to obtain a chondrocyte population that is then
expanded in vitro to yield up to 50 million cells.13 A second operation is performed to
then implant these chondrocytes into the defect and seal them in place using a
membrane (often a periosteal flap). Using a patient's own cells avoids potential
immune responses or the possibility of viral infections from transplanting allogeneic
cells or foreign materials, and as opposed to autologous osteochondral implantation
that requires significantly more tissue, the small biopsy minimizes complications for
the chondrocyte donor.14,15
Studies of ACI in the clinic have yielded mostly positive results - a study
comparing ACI to autologous osteochondral transplantation (mosaicplasty) found ACI
to have superior clinical results 10 years postoperatively, and ACI exhibits superior
outcomes relative to microfracture for the treatment of larger cartilage defects (i.e., >3
cm2 in size).16-21 For smaller defects, however, ACI does not seem to yield clinical
benefit compared to microfracture, even though ACI is generally reported to improve
structural repair.16,21,22 Importantly, this technique requires two operations and a
prolonged recovery time of up to 12 months to ensure maturation of the neotissue,
and even then, outcomes are often influenced by uncontrolled hypertrophy of the
periosteal flap.13,23
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Notably, neither microfracture or ACI employ 3D scaffolding to control where
cells reside and to instruct the formation of extracellular matrix (ECM). Some additional
innovations based on these therapies have been developed in the clinic to address this,
as scaffold-based approaches are noted to generally better fill cartilage defects,
exhibit fewer donor site complications (i.e., periosteal flap harvest not typically used),
and involve a potentially less challenging procedure with shorter recovery times for
patients due to increased graft stability.13 Additionally, because the chondrocytes are
cultured in a 3D environment, they are less prone to dedifferentiation and therefore
produce a more hyaline cartilage similar to that of articular surfaces.24 Furthermore, in
vitro culture of cells in these scaffolds prior to implantation may assist in quality
control of scaffold-based repair.13
Matrix-induced autologous chondrocyte implantation (MACI) is a cell-based
therapy that supplements ACI by providing chondrocytes with a supportive 3D scaffold
material for matrix formation.13 MACI also requires two surgical procedures, however:
the first surgery collects autologous tissue for chondrocyte isolation, and this cell
population is expanded in vitro and subsequently cultured on an absorbable porcinederived mixed collagen (type I/III) membrane. These membranes are specifically
engineered to promote chondrocyte infiltration on one side and minimize friction on
the surface that faces the joint space.13 The second procedure includes a miniarthrotomy to debride the lesion area, followed by positioning and securing of the
seeded matrix with the cell-laden side facing the subchondral bone. Whether or not
MACI is overall superior to other approaches is yet to be seen in the clinic, and the
the added expense associated with this technique is a non-trivial consideration for its
adoption.24-26 One prospective randomized clinical trial comparing ACI and MACI
reported comparable clinical, arthroscopic and histological outcomes with both
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procedures, but the MACI-treated group did report a lower rate of graft hypertrophy.26
Meanwhile, a separate study found that Lysholm and Guillquist knee functionality
scores showed better outcomes with ACI than MACI.27 Another study did find
outcomes with MACI to be superior to microfracture for patients with larger (i.e., >4
cm2) defects after 2 years.28
Meanwhile,

a

another

approach

called

autologous

matrix-induced

chondrogenesis (AMIC) improves upon the microfracture technique by introducing an
acellular scaffold into the lesion immediately after microfracture to help improve
mechanical stability, control cell migration, and hopefully influence cartilage production
to fill the the defect site with robust tissue.6 One clear advantage of this procedure is
that it only requires a single operation: in this operation, a mini-arthrotomy debrides
the defect site, microfracture releases blood components and bone marrow containing
MSCs into the defect, and then a mixed collagen type I/III matrix is sutured or glued
into the defect.6 The implanted collagen matrix is thought to stabilize the resulting
blood clot, helping to promote early mechanical stability and cartilage regeneration.
Case studies have found AMIC to be both safe and effective in treating full-thickness
cartilage defects.29-31
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1.3. CARTILAGE TISSUE ENGINEERING FOR TISSUE REPAIR
Cartilage tissue engineering seeks to meet the clinical need for repair of
damaged cartilage tissue by employing unique combinations of materials, cells, and
signals to generate new cartilage tissue (Figure 1.3). Combinations of these various
elements produce a variety of interesting approaches such as scaffold-free techniques,
self-assembly, ex vivo culture, and cell-free scaffold engineering. Some of the more
recent clinical approaches discussed here, such as MACI and AMIC, fall within this
paradigm as well.

Figure 1.3. Paradigm for tissue engineering of articular cartilage. The major
elements of approaches that use tissue engineering are cells, stimulants, and scaffolds.
Different cell types (autologous, allogeneic, and stem/progenitor) have been tested in
vitro and in vivo for their chondrogenic potential. A variety of biochemical and
biomechanical stimulants have been employed to influence cell differentiation and
construct maturation. Scaffolds support and improve the formation of neotissue by
maintaining or influencing cell phenotypes, delivering cells, and/or recruiting cells from
the host. Adapted from Kwon et al.37
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A variety of cell types have been proposed as candidates for cartilage repair,
including chondrocytes,32 adult progenitor cells such as mesenchymal stromal cells
(MSCs) from various sources,33,34 induced pluripotent stem cells,35 and even
fibroblasts.36 With clinical relevance in mind, chondrocytes and MSCs have emerged as
leading candidates among the cell types studied. Chondrocytes are the resident cells in
cartilage tissue that are essential for cartilage ECM production and maintenance and
thus represent a logical choice for cartilage engineering. Isolating chondrocytes directly
from the joint, however, proves difficult and also creates secondary injury to the joint,
leading to further tissue degradation.11
As a result, non-articular “heterotopic” chondrocytes such as nasoseptal or
auricular chondrocytes have attracted interest as an alternative cell source. These have
proved easier to harvest with lower risks related to donor-site morbidity.38-41 It remains to
be seen whether these heterotopic chondrocytes can be induced to produce tissue that
is functionally appropriate for orthopaedic applications. One of the additional challenges
of using chondrocytes for transplantation is maintenance of phenotype during their
expansion in vitro by means of, for instance, chondrocyte sorting,42 cytokine
stimulation,43 or control of oxygen exposure;44 chondrocytes expanded too extensively
may also lose their capacity to re-differentiate.45 Moreover, chondrocytes fail to form
bone tissue in the subchondral zone of full-thickness osteochondral defects.32
MSCs are a clinically relevant multipotent cell type that can be readily derived
from a variety of adult tissues.46,47 Bone marrow-derived MSCs can undergo
chondrogenesis by induction with soluble factors such as cytokines, ideally within a 3D
culture environment (e.g., cell pellets, micromasses, or encapsulation into 3D scaffolds)
that is developmentally relevant. For in vitro culture, the addition of soluble factors such
as TGF-β generally stimulates enhanced chondrogenesis in a dose-dependent manner;
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at the appropriate dose, this enhances chondrogenesis regardless of culture method or
scaffold, but the degree of chondrogenesis is still scaffold-dependent.48 For example,
MSCs produce greater quantities of sulfated GAGs in alginate over agarose gels in
response to TGF-β.48 To date, numerous scaffold materials have been used in
conjunction with media containing TGF-β and other chondrogenic supplements towards
the differentiation and phenotype maintenance of cells, including: agarose,48,49 alginate,48
poly(ethylene glycol) (PEG),50 poly(glycolic acid) (PGA),51 silk,52,53 poly(DL-lactic-coglycolic acid)-collagen (PLGA-collagen) meshes,54 gelatin/chondroitin/hyaluronic acid tricopolymer,55 and electrospun polycaprolactone (PCL).56 In addition to TGF-β, the cycling
of growth factors (BMP-6 and IGF-1) during in vitro culture can also influence
chondrogenesis.57 Cultures of MSCs with components of the joint cavity, like synovial
fluid or synovial cells, exhibit enhanced chondrogenesis in vitro as well.57

1.4. MSC-LADEN HA HYDROGELS FOR CARTILAGE TISSUE ENGINEERING
Due to their biological relevance to the origins of cartilage tissue in development,
as well as their clinical relevance as a cell type that can be readily harvested and
expanded, MSCs have gained significant interest in cartilage tissue engineering as an
alternative to chondrocytes. In 1998, bone marrow derived MSCs were found to undergo
chondrogenesis when cultured in cell aggregates in the presence of TGF-β1.58 However,
one major limitation of these MSCs is the mechanical integrity of the matrix they produce
in the engineered environments that have been developed to encapsulate and deliver
them thus far.59 In a long-term agarose culture, for instance, chondrogenesis was
observed in the MSC-laden gels, but the amount of matrix produced and mechanical
properties were inferior to that produced by chondrocytes from the same donor.59 The
glycosaminoglycan (GAG) content and the equilibrium modulus of these MSC-laden gels
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plateaued with time, which suggests diminished chondrogenic capacity rather than
delayed differentiation of these cells.
In general, the use of inductive biomaterials in the cells-in-hydrogels approach to
tissue engineering has been deemed to be favorable compared to that of inert but
permissive materials, e.g., alginate and polyethylene glycol (PEG) (Figure 1.4).60,61 For
this approach, hyaluronic acid (HA), a linear polysaccharide that consists of disaccharide
repeats of D-glucuronic acid and N-acetyl-D-glucosamine, has emerged as one of the
most studied inductive biomaterials.62 In fact, among the numerous cell-material
formulations developed toward this end, hydrogels that make use of this native cartilage
ECM component have been used to successfully mimic characteristics of cartilage
developmental structure and signaling, and formulations using this macromer with low
gel densities (to reflect minimal early ECM deposition) and high cell seeding densities
(approaching that in a developing embryo), coupled with transient presentation of prochondrogenic factors, have demonstrated the greatest final mechanical functionality of
those studied.60,61,63
The primary hydroxyl and carboxylic acid groups on the HA backbone are readily
functionalizable for the fabrication of hydrogels with highly tunable properties and such
functionalized HA macromers have been used for photocrosslinking as well as covalent
tethering of a variety of crosslinkers, peptides, and even full-length proteins that mimic
aspects of the native microenvironment.64-69 For instance, photopolymerization of HA can
be achieved via the modification of HA with methacrylate pendant groups (i.e., MeHA),
and by further varying the molecular weight and macromer concentration of the modified
HA, a wide range of properties can be obtained.60,64,65 Increasing the macromer
concentration can significantly increase the network compressive modulus and
degradation time but decrease the viability of encapsulated cells.64 Degradability of the
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network can also influence cell behavior in these scaffolds such that cells in dynamic
systems with decreasing gel concentration over time produce more matrix components;
these variations in hydrogel scaffold properties can thus affect neocartilage formation,
where evidence of chondrogenesis is typically characterized by enhanced type II
collagen and aggrecan expression and accumulation.70,71

Figure 1.4. Comparison of MSC chondrogenesis in HA versus PEG hydrogels.
Immunohistochemistry of MSCs cultured in HA or PEG hydrogels for 14 days in vitro.
Deposition of type II collagen and chondroitin sulfate by MSCs is increased in an HAbased material compared to an inert PEG gel. Adapted from Chung et al.61

Substantial efforts have been made to characterize the effects of these various
gel properties on cells’ ability to produce neotissue: screens of 1, 2, and 5 wt% MeHA
hydrogels seeded with bovine MSCs found that MSCs within 5 wt% MeHA hydrogels
significantly upregulated mRNA expression of type II collagen and resulted in the highest
overall proteoglycan deposition relative to lower concentration hydrogels.72 However, the
high network density also impeded the distribution of the deposited matrix and resulted
in inferior bulk mechanics compared to the other conditions. Indeed, the 1 wt% hydrogel,
although not optimal for matrix production and possessing the lowest initial mechanical
properties, resulted in the highest equilibrium compressive modulus (0.12 MPa) and
dynamic modulus (1.05 MPa) of all conditions after 6 weeks of in vitro culture.72 Thus, it
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is important to balance the initial properties with the ability to accumulate matrix within
these hydrogel systems to obtain the best final properties in engineered tissues, towards
their utility in clinical applications.
Analogous findings were obtained in studies in vivo.60 For instance, in an in
vivo rabbit cartilage defect model, the quality of tissue repair using MSCs encapsulated
in HA-gelatin hydrogels depended on the supporting scaffold - defects treated with
MSCs in the absence of any supporting scaffold exhibited hyaline-like cartilage on the
periphery but fibrous repair tissue in the middle of the defect, whereas defects that were
treated with a scaffold containing MSCs resulted in elastic and mechanically stable
translucent cartilage with zonal architecture and substantial integration with the
surrounding cartilage.73
In addition to investigating the effects of gel properties, the effects of varying cell
parameters in these constructs have also been explored - in one study, a higher cell
seeding density of 60 million cells/mL (60M) was compared to a standard density of 20
million cells/mL (20M) within 1wt% MeHA hydrogels. Hydrogels containing 60M cells
reached a significantly higher equilibrium compressive modulus and dynamic modulus
compared to the ones containing 20M cells—presumably due to increased cell-cell
proximity

and

thus

increased

paracrine

signaling

and

extracellular

matrix

connectivity.74,75 Interestingly, the GAG concentration was only ~25% greater and the
collagen content was surprisingly halved in the 60M group, implying that the increase in
mechanics was more likely due to enhanced collagen organization and connectivity.

74,75

Importantly, the effect of higher network densities was not overcome even by this 3-fold
difference in cell density - the mechanical properties of constructs after culture did not
increase in gels containing 60M versus 20M cells encapsulated in in 2wt% and 5wt%
MeHA hydrogels.74
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Hydrogel environments may also alter or influence cellular mechanosensitivity
and responsivity to various mechanical loading regimes. Mechanical properties of bovine
MSC-seeded MeHA hydrogels improved significantly after continuous loading in
comparison to the moduli of identical samples under delayed loading and static culture
conditions, such that the MeHA-based constructs exhibited significant improvements in
mechanical properties even with early application of dynamic loading whereas this was
not the case with agarose gels.76 The different responses to compressive loading within
MSC-seeded HA gels compared to other systems like agarose and PEG may be due to
specific receptor mediated interactions with HA, including CD44.77 Although the
underlying mechanisms remain yet to be fully defined, the finding that compressive
mechanical loading can significantly enhance mechanical properties within HA hydrogels
while not in inert ones provides some important clues and valuable insight into culture
environments.
However, without considering the full microenvironmental context (e.g., cellmatrix, cell-cell interactions) required for this cell population to differentiate into a desired
cell type, the expected phenotypic outcome is incomplete commitment even in the
presence of pro-chondrogenic differentiation factors. This would, in turn, limit matrix
deposition and potentially promote matrix heterogeneity within the construct. In fact, this
is what has been observed in many of the aforementioned studies, with limited
chondrogenesis and heterogeneity in extracellular matrix deposition.78 This poses a
major challenge for cell delivery and tissue engineering with adult MSCs.
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1.5. CARTILAGE DEVELOPMENT AND HOMEOSTASIS
To design appropriate cartilage tissue engineering strategies, we should look to
our understanding of the adult tissue composition and structure, as well as an
understanding of how the tissue develops. Mature articular cartilage contains a sparse
resident population of chondrocytes and a dense ECM that comprises most of the tissue
volume.79 This ECM is comprised largely of type II collagen (15 to 22% of wet weight),
proteoglycans containing aggrecan (4 to 7%), and high fluid content (65 to 80%).80
The development of articular cartilage occurs in the context of direct cell-matrix
and cell-cell interactions that are present as this tissue forms out of the mesenchymal
lineage.81 Before differentiation, or chondrogenesis, MSCs produce a mesh that is
mainly composed of HA.77 HA is remodeled in the mesenchyme throughout the early
stages of chondrogenesis in the developing embryo to help orchestrate both cell-cell
interactions and subsequent matrix deposition.77,82,83 HA-cell interactions are mediated
via the principal cell-surface receptor CD44, which is understood to induce chondrogenic
differentiation

via

interactions

with

other

cell-surface

receptors

relevant

to

chondrogenesis, as well as via nuclear translocation of transcription factors such as
Smad4, c-Myc, and E2F4 (Figure 1.5) .84-87
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Figure 1.5. Generalized HA signaling pathway mediated by CD44-HA interactions.
HA interactions with CD44, which can interact with and activate other receptors on the
cell surface, can influence the transcription of genes required for chondrogenic matrix
synthesis via intermediates such as transcription factors c-Myc, E2F4, and Smad4 (not
pictured). Adapted from Responte et al.87

The first phase of cartilage development, referred to as the condensation phase,
is marked by the aggregation of mesenchymal cells, and changes in both HA-binding
activity and CD44 expression coincide with this reduction in intercellular space at regions
marked for future cartilage deposition.88 The cell-surface protein N-cadherin is
considered to be the key component in directing these cell-cell interactions.89,90
Interestingly, MSCs increase N-cadherin expression upon exposure to media containing
pro-chondrogenic factors.91 The structures of the classical cadherins, including NCadherin, include an extracellular binding domain that mediates cell-cell interactions in a
calcium dependent manner, as well as intracellular domains that interacts with signaling
mediators such as β-catenin (directly via the cytoplasmic tail), p120 catenin (directly via
the juxtamembrane region), and α-catenin (indirectly via β-catenin; Figure 1.6).92
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Figure 1.6. Schematic of N-Cadherin-catenin complex. N-Cadherin is a Ca2+dependent single-pass transmembrane protein that mediates cell-cell interactions via its
extracellular domain, which is composed of 5 tandem repeats with the HAV (histidinealanine-valine) motif that confers homotypic specificity on the N-terminus. The
cytoplasmic domain is capable of sequestering β-catenin at the cell membrane, and it
can thus also interact with the cytoskeleton via α-catenin. Adapted from DeLise et al.92

N-cadherin signaling intersects with the Wnt signaling pathway via its interactions
with β-catenin.91 When ligands for Wnt are present, β-catenin translocates to the nucleus
where it can act at TCF/LEF promoters to activate target genes (e.g., MMP3, MMP7,
ADAM10, Twist, Slug, Tiam1, Fibronectin, and cyclin D1).93 Functionally, both the
extracellular homotypic interaction with other cadherins and the intracellular interactions
with the catenin complex are essential for N-cadherin signaling - expression of deletion
mutants of N-cadherin that lack either the extracellular interaction domains or the
intracellular β-catenin binding site results in decreased cellular condensation and
impaired chondrogenesis.94,95 In addition to deletion of either its intracellular or
extracellular domains, the degree of expression of full-length N-Cadherin and its
subsequent ability to bind in the face of other soluble factors both affect chondrogenesis
as well - the significant overexpression of full- length protein or inhibition of N-Cadherin
interactions

via

blocking

antibody

treatment

inhibit

condensation

and/or

chondrogenesis.61,96 In particular, the evolutionarily conserved His-Ala-Val (HAV)
sequence in the first extracellular domain (ECD1) of N-cadherin has been identified as
essential to the homotypic interaction that mediates cell-cell adhesion in this context.97
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Notably, in the mesenchyme, the cell-surface metalloprotease ADAM10 temporally
regulates N-Cadherin interactions by cleaving the extracellular domain that is
responsible for cell-cell binding,98 thereby regulating both the β-catenin membranebound and cytoplasmic pool levels.89,98,99
An additional layer of spatiotemporal complexity in chondrogenesis is the fact
that MSCs synthesize, deposit, and even remodel both their PCM and ECM as they
differentiate.100 Various cell types are capable of organizing their pericellular matrix
within hours; chondrocytes in particular are capable of organizing a stable pericellular
coat of matrix components in as few as 30 minutes, and they are able to synthesize a
pericellular matrix that fully surrounds the cell membrane in as few as 24 hours.101,102

1.6. CONCLUSIONS
Articular cartilage injury is a widely prevalent condition that leads to a
progression of degenerative changes in the joint space. Current treatment methods fall
short of long-term tissue repair, and they often miss the complex spatiotemporal
microenvironmental cues required for cartilage development, repair, and homeostasis. In
response to the fact that cartilage is cell-sparse and has poor inherent regenerative
capacity, cell-laden hydrogels have emerged as a suitable approach to cartilage repair.
These hydrogel environments are being engineered with microenvironmental cues to
promote cell differentiation, matrix synthesis, and construct maturation. Materials
designed for the fabrication of these hydrogels can make use of the current
understanding of developmental processes, specifically by addressing both the cell-cell
and cell-matrix interactions that are required for chondrogenesis, as well as the timing of
presentation of such cues.
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CHAPTER 2
RESEARCH OVERVIEW

2.1. SPECIFIC AIMS
Cell-laden hyaluronic acid (HA) hydrogels have been adopted as a promising and
extensively studied approach to cartilage repair.1 Advances in the designs of these
hydrogel

environments

now

consider

how

they

can

mimic

or

recapitulate

microenvironmental cues that promote relevant cell differentiation, matrix synthesis, and
construct maturation. Specifically, these can include interactions between cells and the
HA that forms the hydrogel via surface receptors (e.g., CD44), as well as the cell-cell
interactions that are essential in the early stages of cartilage tissue development.
The use of HA in these approaches introduces potential biological activity to the
hydrogel, such as through binding with the cell-surface receptor CD44 - indeed, this
biologically relevant interaction may serve to explain why HA hydrogels are superior to
polyethylene glycol (PEG) hydrogels when directly compared toward cartilage tissue
engineering with increased extracellular matrix (ECM) synthesis and chondrogenic
differentiation of MSCs observed when HA is used.2 However, the modification of HA
through the primary alcohol or carboxylic acid groups is needed to enable crosslinking
into hydrogels. These groups may play a role in the interactions with CD44; thus,
modification would likely influence the final macromer’s actual biological activity and
therefore its ability to promote chondrogenesis. For instance, the modification of the
highly charged and hydrophilic carboxylic acid on the HA backbone with hydrophobic
groups may alter its solubility, range of possible conformational states, and receptor

affinities. This has in fact been exploited for the development of HA-based macromers
with longer half-life, efficacy, or cargo delivery properties that are now used in
commercial fillers and viscosupplements.3 There is still a great need to further
understand how HA modification influences its activity in the context of cartilage repair.
Meanwhile, the introduction of direct cell-cell interactions into the cell
microenvironment is challenging due to difficulties in controlling cell behavior in
aggregates and maintaining cell viability in large pellets. An alternative approach is to
simulate cell-cell interactions within 3D hydrogels where cells are uniformly suspended
as single cells and therefore unlikely to come into direct contact with other cells.
Specifically, the conserved short sequence, His-Ala-Val (HAV), on the adhesive domain
on N-Cadherin can be exploited to mimic N-Cadherin-like binding activity via the
incorporation of short peptides.4-7 Incorporation of these N-Cadherin mimetic peptides in
HA hydrogels has indeed promoted early chondrogenic gene expression and
subsequent matrix production of MSCs in culture and in vivo4 and resulted in increased
β-catenin recruitment to the membrane and subsequent translocation to the nucleus to
mediate downstream N-Cadherin signaling.8 However, N-Cadherin signals in the
developing limb exhibit wide spatiotemporal variation, with high persistent levels of
Ncad-mediated cell-cell contact possibly even reducing collagen and proteoglycan
deposition.9 Prior to this thesis, the magnitude and timing of the presentation of these NCadherin mimetic signals, which are two critical aspects of this essential interaction that
directly influence signaling, were yet to be explored.
As these various types of modifications (e.g., reactive groups, peptides) are
increasingly used to functionalize materials such as HA for applications in tissue
engineering, it remains unclear when, and for how long, the actual presentation of these
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signals occurs. The spatial arrangements of these newly synthesized matrices in a
hydrogel setting where the polymer initially occupies this space in the cell
microenvironment is not well characterized. Recently, high-resolution imaging of total
nascent pericellular matrix (PCM) synthesized by cells in hydrogels have been
developed to probe spatiotemporal matrix organization, and the use of these methods in
the context of tissue engineering has yielded valuable insights into cell-to-cell variations
in PCM deposition and retention.10 Such methods for visualization and quantification of
total matrix synthesis and deposition by cells, in combination with the ability to visualize
the spatial localization of the hydrogel itself, help inform how we can engineer cues to be
biologically relevant in their presentation.
The overall goal of this thesis is to advance the design of cell-laden HA hydrogels
for cartilage tissue engineering by investigating the influence of the extent and timing of
the presentation of critical early cues in the context of chondrogenesis. Specifically, as
outlined in the following aims, we evaluate these parameters using both innovative
techniques as well as in vitro models that enable observation of both early differentiation
and bulk construct maturation. We also utilize single-cell assessments to characterize
the dynamic MSC interactions with these early hydrogel cues over time.

Aim 1: Probe the influence of HA modification on CD44-mediated MSC
interactions with HA hydrogels
Hypothesis: Modifying HA decreases binding to CD44 as a function of modification level
and location and influences chondrogenesis of MSCs when encapsulated in HA
hydrogels.
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It is known that MSCs bind to HA through CD44 receptors, and that HA
hydrogels are superior in supporting ECM synthesis by fully differentiated chondrocytes
as well as by MSCs;11,12 yet, the influence of HA modifications (e.g., norbornene or
methacrylate, used to crosslink HA into hydrogels) on these interactions is not well
understood. It has been reported that a minimum number of 4 disaccharide repeats is
needed on HA for CD44 binding; thus, modification is expected to influence these
interactions.13 To better understand these interactions, HA with varying degrees and/or
sites of modification with norbornene and methacrylate groups are synthesized and used
in soluble form or as hydrogels with matched mechanics, swelling, and cytocompatibility.
The effects of the degree of modification are examined first by observing the binding
avidity of modified HA to either CD44 or directly to the surface of MSCs. Atomic force
microscopy using receptor-functionalized beads on hydrogels containing HA with varying
degrees of modification is then used to evaluate CD44 interactions with HA when
crosslinked into hydrogels. Lastly, the influence of HA modification level on the
chondrogenesis of MSCs encapsulated in these hydrogels is explored with outcomes of
gene expression, biochemical content, mechanics, and histology. These studies provide
a perspective on the design and evaluation of modified biopolymers, where the degree
of modification of the biopolymer may be a key consideration in its interactions with cells.

Aim 2: Investigate the role of the magnitude and timing of N-cadherin signals to
MSCs within HA hydrogels towards chondrogenesis
Hypothesis: Varying the amount and extent of HAV peptide presentation within HA
hydrogels alters chondrogenesis of encapsulated MSCs.
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We previously showed that modification of hydrogels with a peptide (i.e., HAV)
that mimics N-Cadherin influences MSC chondrogenesis and matrix production;4,8
however, this was presented to cells only at one concentration and with a stable linker.
To better understand the role of HAV in altering MSC chondrogenesis both the HAV
magnitude and the timing of HAV are examined using stable and transient peptides
when coupled to HA hydrogels. Importantly, in the mesenchyme, cell-surface
metalloprotease ADAM10 temporally regulates N-Cadherin interactions by cleaving the
extracellular domain of N-Cadherin, thereby exerting control over the β-catenin
membrane-bound and cytoplasmic pool levels.14-16 Thus, the timing of HAV is modified
by the incorporation of ADAM10-cleavable peptides, so that its presentation is selfregulated by cells via ADAM10. The role of HAV signal magnitude and timing is tested
using hydrogels with matched mechanics, swelling, and total peptide content with
longitudinal assessments of MSC gene expression, matrix elaboration, and construct
properties. These studies elucidate how the magnitude and timing of presentation of this
important early cell-cell cue in materials influences chondrogenesis and information
gained can be used to better design appropriate hydrogel approaches for cartilage
repair.

Aim 3: Investigate the deposition of pericellular matrix by cells within HA
hydrogels using metabolic labeling techniques.
Hypothesis: Early pericellular matrix produced by cells encapsulated within HA
hydrogels forms a barrier between the cell membrane and the hydrogel, temporally
altering the presentation of hydrogel signals to cells.
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As hydrogels comprised of bioactive molecules (e.g., HA) or with peptide
modifications (e.g., HAV) are developed, it is important to understand how long these
signals are actually presented to cells encapsulated within hydrogels. Towards cartilage
tissue engineering, cells synthesize and deposit a PCM17 that alters their local
microenvironment; yet, it is not well understood how this influences the presentation of
engineered signals too cells. Nascent pericellular matrix (e.g., proteins, proteoglycans)
deposited by cells can be visualized via metabolic labeling and hydrogel positioning can
be monitored with encapsulated fluorescent beads. Parallel longitudinal studies using
bead-labeled gels in combination with metabolic labeling are performed to visualize and
quantify temporal changes in pericellular matrix deposition and the distance between the
cell membrane and the hydrogel. This approach enables examination of this critical cellmaterial interfacial region in hydrogels over time, and is used to assess this interface
where critical hydrogel parameters, such as crosslink density and macromer
concentration are varied.

These results will help inform hydrogel design and the

introduction of bioactive signals to modulate cellular behavior.

2.2. CHAPTER OUTLINE
Chapter 1 provides an overview of the clinical landscape for cartilage repair as
well as various cartilage tissue engineering approaches being developed, including the
use of MSC-laden HA hydrogels. It also summarizes the relevant biological aspects of
cartilage development and homeostasis that may be used in designing new tissue
engineering strategies. Chapter 3 consists of a focused summary of highlights in current
and emerging advances in hydrogel design for cartilage tissue engineering. In particular,
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unique crosslinking methods, processing techniques, and the incorporation of
biologically relevant signals to influence cell behavior are discussed.
Chapter 4 describes the scientific work proposed in Aim 1, describing the effects
of the extent and type of HA modification on its interactions with CD44. Chapter 5
describes the research proposed in Aim 2, which characterizes the influence of the
dosing and timing of N-Cadherin mimetic peptide interactions on MSC chondrogenesis
in HA hydrogels. Chapter 6 describes the work proposed in Aim 3, exploring the
relationship between various hydrogel properties and the elaboration of PCM at the cellhydrogel interface.
Chapter 7 provides a summary of the work presented and discusses the overall
impact of this work on the design of HA hydrogels towards cartilage tissue engineering.
Limitations and future directions of this work that may further inform HA hydrogel design
will also be described.
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CHAPTER 3
RECENT ADVANCES IN HYDROGELS FOR CARTILAGE TISSUE ENGINEERING

Adapted from:

Vega SL, Kwon MY, Burdick JA. Recent advances in hydrogels for cartilage tissue
engineering. Eur Cell Mater. 2017;33:59-75.

3.1. INTRODUCTION
In simplistic terms, articular cartilage is a tissue consisting of a single cell type
(chondrocyte) embedded within an extracellular matrix (ECM). However, the structure is
more complex and includes three depth-dependent layers: the superficial zone, the
middle zone, and the deep zone, with changes in ECM content, structure and
chondrocyte behavior with depth. In the middle zone – the largest region, cartilage tissue
is stiff, avascular, and features a low density of rounded chondrocytes surrounded by an
ECM consisting of glycosaminoglycans (GAGs) and type II collagen.1,2 Cartilage damage
due to trauma typically begins as a focal defect, which later progresses to a fullthickness defect once the lesion comes into contact with surrounding bone. Due to low
cellularity, low vascularization, minimal proliferative capacity of residing chondrocytes,
and low cell migration to areas of damage, articular cartilage is intrinsically unable to
repair itself.3
Current strategies to repair focal and full-thickness cartilage defects have
evolved from surgery aimed to induce endogenous repair mechanisms (e.g.,
microfracture), towards osteochondral transplantation, and more recently to cell-based
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repair techniques, such as autologous chondrocyte implantation (ACI).4,5,6 ACI is a
procedure in which patient chondrocytes are implanted into a debrided cartilage lesion.7
Both microfracture and ACI lack 3D scaffolds to define where cells reside and to instruct
matrix formation; however, there have been advances in these therapies in recent years.
Matrix-induced autologous chondrocyte implantation (MACI) is a cell-based therapy that
supplements ACI by providing chondrocytes with a supportive scaffold material for
matrix formation.8 Autologous matrix-induced chondrogenesis (AMIC) on the other hand
supplements microfracture with an acellular scaffold in the lesion in an effort to increase
mechanical stability at the site, cell migration, and cartilage production.9 Despite
promising results, these clinical techniques are not without their limitations, including the
surgical procedures and the quality of the formed cartilage.
Towards further expanding on the use of biomaterials in cartilage repair,
hydrogels have gained a great deal of interest in cartilage tissue engineering.10
Hydrogels are 3-dimensional (3D) polymer networks that are highly swollen and porous
on the molecular scale, allowing for the diffusion of various solutes and nutrients. Their
fabrication can be cell amenable, allowing for the encapsulation of different cell types
(e.g., chondrocytes, stem cells). Lastly, an assortment of hydrogel parameters can also
be tuned, including polymer chemistry, crosslinking density, degradation, mechanical
properties, and release kinetics of biochemical factors, towards improving their utility in
tissue repair.11 Seminal studies have characterized the effects of hydrogel properties
(e.g., macromer molecular weight, macromer concentration) on neocartilage formation,12
and have also studied differences between the composition of hydrogels towards
cartilage formation. For example, several groups report that type II collagen hydrogels
induce a higher amount of chondrogenic outputs in comparison to type I collagen
hydrogels with similar properties.13,14
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To serve as constructs to replace articular cartilage, hydrogels have been used
as either acellular scaffolds or as cell-laden biomaterials.11 For either strategy, hydrogel
implants must integrate with surrounding tissue and support the production of cartilage.
Acellular constructs are almost exclusively assayed in vivo, where the goal is structural
and mechanical properties similar to native cartilage while allowing efficient load transfer
or to recruit cells for cartilage repair.15,16 Cell-laden hydrogels present residing cells with
either developmental cues to trigger chondrogenesis, or microenvironmental cues that
mimic native cartilage to maintain a chondrogenic phenotype and encourage matrix
formation. Hydrogels are advancing to present these signals either as bound to the
polymer or through the controlled release of molecules. Also, these cultures may be
performed in vitro, such as with bioreactors, or may be implanted directly for tissue
growth.
With the rapid advances being made towards hydrogels for cartilage tissue
engineering, the goal of this review is to cover current and emerging developments in
hydrogel design for cartilage repair. It is not meant to be comprehensive, but rather
highlight representative advances in the field in recent years with a particular focus on
the hydrogel design. Specific areas include the use of unique crosslinking to produce
hydrogels with high mechanical properties, the improved processing of hydrogels into
macroporous structures, and the incorporation of biological signals to improve cell
behavior.
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3.2. IMPROVEMENTS IN HYDROGEL STRUCTURE
One of the key design criteria for hydrogels towards cartilage regeneration is
mechanical integrity. Traditional hydrogel designs based on networks of a single polymer
generally result in hydrogel constructs with mechanical properties far inferior to those of
native cartilage. Also, the increase in mechanics through increased crosslink density
may compromise the viability of encapsulated cells through reduced diffusion. Towards
increasing the mechanical properties of hydrogels to approach those of hyaline cartilage,
the focus is shifting from conventional hydrogels that use a single polymer for hydrogel
fabrication (Figure 3.1a), to more complex hydrogel systems with mixtures of multiple
polymers, often including two or more independent networks. These systems not only
often achieve higher mechanical properties than with networks of single polymers, but
may exhibit superior integration with surrounding tissue in vivo. In this section we
examine recent advances within the framework of different network types (Figure 3.1).

3.2.1. INTERPENETRATING NETWORKS
Hydrogels based on interpenetrating networks (IPNs) are comprised of two or more
separate crosslinked networks not covalently bound to each other, but rather partially
intertwined such that chemical bonds have to be broken to separate the components
that make up the networks (Figure 3.1b). Consequentially, the mechanical properties of
IPN hydrogels tend to be greater than those created with individual component
networks, which makes them appealing for cartilage tissue engineering applications. In
recent years, the design of IPNs for hydrogel formation has turned to the incorporation of
two or more additional networks to either better mimic the physical properties of native
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tissue or to recapitulate the presentation of bioactive cues available to cells in the
hydrogel constructs.

Figure 3.1. Schematic depicting different designs utilized in hydrogels. (a)
Traditional single polymer networks, (b,c) multiple networks, and (d-f) mixtures of
polymers. Double networks may be linked together, but this is not a requirement.
Generally, the network design controls properties such as mechanics and degradation.

Recent examples of IPNs include work done by Ingavle et al., in which they
explored the incorporation of methacrylated chondroitin sulfate, a major component of
the cartilage ECM, as the second network after diffusion into an existing agarosePEGDA network.17 Incorporating chondroitin sulfate into the network significantly
increased the viability of encapsulated chondrocytes for at least six weeks, and
promoted greater biosynthesis of collagen and GAGs in the pericellular matrix.17
Reinforcing networks such as those provided by methacrylated hyaluronic acid (HA)
within a fibrin hydrogel have been demonstrated as well (Figure 3.2a).18 Here, the
investigators found that the incorporation of a crosslinked HA network increased the
compressive moduli of hydrogel constructs and modulated gene expression of
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encapsulated human mesenchymal stem cells (MSCs) by decreasing expression of
dedifferentiation marker type I collagen and increasing expression of the chondrogenic
transcription factor Sox9.18

Figure 3.2. Examples of network types applied in cartilage tissue engineering. (a)
SEM micrograph of a fibrinogen hydrogel with (bottom) and without (top) interpenetrating
methacrylated HA network.18 (b) MSCs encapsulated in gelatin methacrylamide
hydrogels exhibit more aggrecan (green) with increasing concentrations of
methacrylated HA, which acts as a dual network.31 (c) Hydrogel molecular structures
and crosslinking schemes can become quite complex, as seen by this schematic
depicting supramolecular hydrogels prepared with CB[6]-HA, DAH-HA, and drug
conjugated Dexa-CB[6].39

In addition to IPNs of two networks, several groups have also investigated how
tri-component IPNs increase mechanical properties and cartilage formation using both
non-cell instructive19,20 and cell-instructive materials.21 In a non-cell instructive scaffold
comprised of gelatin, alginate, and polyacrylamide, Dinescu et al. reported higher cell
proliferation, lower cytotoxicity, and greater chondrogenic gene expression (Sox9, type II
collagen) of human adipose-derived stem cells than in one- or two-component
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hydrogels.19 The authors attributed these findings to the tri-component network’s ability
to better retain its internal structure and porosity in long-term culture.19 Guo et al. further
used this tri-component IPN concept to better approximate the diversity of biomaterials
present in articular cartilage.21 The authors demonstrated the feasibility of generating a
tri-component IPN using only cell-instructive components (collagen combined with
methacrylate-modified chondroitin sulfate and HA).21 By comparing to a semi-IPN using
the same components (where the chondroitin sulfate and HA were not methacrylated)
and by varying the extent of methacrylation, they demonstrated tunable mechanics with
the tri-component IPNs, increased gene expression of chondrogenic markers (i.e.,
aggrecan, type II collagen, and Sox9), downregulation of dedifferentiation marker type I
collagen, and increased collagen and GAG synthesis by encapsulated rabbit
chondrocytes that correlated with the bulk mechanics of the IPN constructs.21

3.2.2. SEMI-INTERPENETRATING NETWORKS
Unlike IPNs, semi-IPNs consist of a crosslinked network with either linear or
branched polymers entrenched within the network (Figure 3.1c). As such, the polymers
and network can theoretically be separated from one another without breaking chemical
bonds. One of the most common macromolecules distributed in these networks is HA. In
a recent study, high molecular weight HA was distributed within injectable networks of
photopolymerized methacrylated chitosan (MeGC).22 An optimum formulation and
gelation protocol was developed, and the presence of entangled (but unbound) HA (350
kDa) incorporated into the chitosan network resulted in greater proteoglycan and GAG
staining (as measured by alcian blue and safranin O) in the lacunae of chondrocytes
encapsulated and cultured for up to 21 days.22
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Another approach towards utilizing the properties of semi-IPNs is exploiting their
ability to leach low-molecular weight macromolecules over time, as demonstrated by
Skaalure et al. in a degradable poly(ethylene glycol) (PEG) hydrogel with low-molecular
weight HA (29 kDa).23 By comparing PEG networks infiltrated by either low- or highmolecular weight HA (2 MDa), the authors found that leaching of low molecular weight
HA over a 28-day period led to the greatest soluble GAG deposition during construct
maturation, while collagen biosynthesis was comparable to that generated in constructs
with high molecular weight HA (which remained in the network during this period).23
Conceptually similar approaches taken by Little et al. suggest that low-molecular weight
HA and chondroitin sulfate in a fibrin-alginate hydrogel may exert post-transcriptional
effects on collagen expression to influence construct composition as cells deposit matrix
over time.24

3.2.3. DOUBLE NETWORKS
A double network consists of two networks with significantly different mechanical
properties crosslinked together (Figure 3.1d). Typically, the first network provides a rigid
structure and the second network is ductile, resulting in greater toughness than the
corresponding single networks alone would have achieved since the network can yield
under mechanical load.25 These types of networks have gained interest in cartilage
tissue engineering due to their superior mechanical properties over traditional hydrogels,
including those that can approach the mechanics of native hyaline cartilage.26 Double
networks are also conceptually appealing since cartilage and other skeletal tissues
inherently incorporate double networks into their ECM in order to achieve their robust
mechanical properties.26
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Commonly utilized double networks for cartilage tissue engineering consist of a
combination of two acrylamide polymers, poly(2-acrylamido-2-methylpropanesulfonic
acid)

(PAMPs),

poly(acrylamide)

(PAAm),

and/or

poly(N,N-dimethylacrylamide)

(PDMAAm).27 Work with these double network hydrogels has recently extended to in
vivo studies in both rabbit and sheep models of critical size defects, in which acellular
plugs comprised of this double network implanted in defects resulted in enriched GAG
and type 2 collagen content as measured by histological staining after 4 weeks.28 In all
cases, the double-network plug was not infiltrated by cells, and instead seemed to serve
as a support material for tissue regeneration above and around it.
A direct comparison between double network hydrogels and traditional single
network hydrogels of either only PAMPS or PDMAAm demonstrated that double network
hydrogel constructs resulted in superior cartilage repair by histological scoring.29 The
tissue formed in the presence of double networks also exhibited similar gene expression
profiles30 and tissue surface roughness to native cartilage, even as observed by confocal
laser scanning microscopy. Furthermore, combinatorial therapies using double network
hydrogels and intra-articular injections (e.g., HA) have shown potential in tissue quality
as measured by histological scoring and the volume of cartilage generated by double
network hydrogels implanted in cylindrical osteochondral defects in rabbit femoral
trochlea at both 4 and 12 weeks—again, using acellular plugs of the PAMPS/PDMAAm
double network.30
With this said, the application of novel and cell-instructive materials for double
network construct design in cartilage tissue engineering has not been widely explored
until recently. Polymers used for double networks are non-degradable, and while this
stability renders them as potentially useful materials for mechanical support in tissue
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defects, this stable and rigid network may limit cell infiltration and impede long-term
matrix deposition and distribution. Despite these properties of double-network hydrogels,
Levett et al. developed a double network consisting of a combination of gelatinmethacrylamide and hyaluronic acid-methacrylate.31 This system leveraged the relatively
higher reactivity of methacrylate groups to create a double network, thus generating
greater increases in compressive modulus and cartilage matrix component synthesis by
encapsulated human chondrocytes.31 New hydrogels making use of this type of network
are continuously being developed, such as an injectable and cytocompatible double
network hydrogel based on HA that is formed through the combination of dynamic (i.e.,
guest host pairs) and stable (i.e., covalent) crosslinks.32

3.2.4. DUAL NETWORKS
Unlike double networks which use two materials with different mechanical
properties, dual networks are defined as two materials crosslinked together into the
same network and with similar crosslinking mechanisms (Figure 3.1e). Although dual
networks do not possess the toughness of double networks, each material in dual
networks can imbue other useful properties to the hydrogel. For instance, one material
can enable effective integration with the surrounding tissue, while the other can attract
cells and encourage migration into the hydrogel. Teixeira et al. utilized a dextrantyramine

and

heparin-tyramine

dual

network

hydrogel

to

encapsulate

bovine

chondrocytes in vitro and reported improved cell viability and proliferation.33 Additionally,
they observed increased deposition of chondroitin sulfate and collagen compared to
cells in a single component dextran-tyramine hydrogel.33 Jin et al. reported similar
findings using the same dual network polymers ex vivo with bovine articular cartilage
explants (0.5 x 0.5 x 0.2 cm) to determine tissue-adhesion of the hydrogel constructs.34
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In a more recent study, in situ forming ethylenediamino-functionalized HA (HA-EDA) and
divinylsulfone-inulin (INU-DV) dual network hydrogels were used to encapsulate
chondrocytes, with the first material selected due to its native presence in articular
cartilage and the second for its biocompatibility and status as a widely-used FDAapproved polymer.35
Along the same lines of using HA as the biologically relevant component, Pirinen
et al. developed a dual network hydrogel using high molecular weight HA (>1,600 kDa)
and low molecular weight PVA (27 kDa) functionalized with aldehydes and primary
amines for crosslinking.36 This dual hydrogel system was amenable to tunable swelling
properties by varying the size of the smaller PVA component, and encapsulation of
bovine knee chondrocytes showed favorable cell viability for at least 2 weeks in
culture.36 Similar hydrogel systems (e.g., with HA and gelatin) have also produced
favorable results in construct formation and maturation. Levett et al. reported that the
addition of HA as the second component resulted in retention of a rounded chondrocyte
morphology, greater aggrecan deposition and compressive moduli, and suppression of
type I collagen accumulation over the course of a 56-day study (Figure 3.2b).31

3.2.5. GUEST-HOST NETWORKS
Injectable hydrogels are an attractive approach for cartilage tissue engineering
since they can be delivered via a direct injection or arthroscopically.37 Shear-thinning
hydrogels are an attractive method towards this as a hydrogel can be disrupted during
the injection process and then self-heal upon injection. One shear-thinning HA system
developed is based on the reversible bonds between guest (adamantane modified HA)
and host (β-cyclodextrin modified HA) polymers, termed guest-host interactions (Figure
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3.1f).38 These types of interactions rapidly form hydrogels via non-covalent interactions
in the guest-host bonds. In addition to cyclodextrin-adamantane guest-host pairs, guesthost

interactions

between

cucurbit[6]uril

and

diaminohexane

have

also

been

investigated.39 Both of these interactions are reversible and give rise to shear-thinning
and re-moldable hydrogels.
Wei et al. described the assembly of a two-component guest-host hydrogel with
adamantane-functionalized HA as the first component and monoacrylated β-cyclodextrin
(assembled into clusters by photopolymerization) as the second component.40 The
hydrogels formed from these components exhibited nanoclustered interactions that
allowed for robust drying and re-swelling without changes in water content or shape;
they also enabled the robust chondrogenesis of encapsulated human MSCs with greater
collagen deposition compared to a covalently crosslinked methacrylated HA network,
although the differences in biophysical properties and network structure limit a direct
comparison.40 Jung et al. demonstrated the use of guest-host interactions between
curcubit[6]uril and diaminohexane to create hydrogels for the encapsulation of human
MSCs as well as simultaneous release of dexamethasone for chondrogenesis. Cells in
this injectable guest-host system, especially with the additional function of controlled
dexamethasone release, exhibited increased cell proliferation, GAG synthesis,
chondrogenic gene expression (i.e., type II collagen, COMP, aggrecan, Sox9), and
neocartilage formation in an in vivo subcutaneous study (Figure 3.2c).39

3.3. ADVANCES IN PROCESSING SCAFFOLDS
Parallel advances in manufacturing technologies and material design have paved
the way for new possibilities in how hydrogels can be manipulated and formed into 3D
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macroporous scaffolds. Architectures that aid in the viability, retention, and chondrogenic
induction of cells have been achieved using several techniques including 3D printing,
spinning, and doping hydrogels with degradable porogens or microspheres (Figure 3.3).
Due to their ability to generate unique microenvironments for cells and better
recapitulate tissue structure on the macroscale, these techniques have become more
prominent in tissue engineering in general and in cartilage engineering in particular.
Recent studies making use of some of these more widely adopted methods are outlined
in the following subsections.

Figure 3.3. Overview of different macroporous scaffold structures used for
cartilage tissue engineering. To create hydrogel fibers, 3D printing and spinning
techniques have been employed (blue box). In contrast, porous hydrogels and
complementary microsphere hydrogels can also be fabricated (red box). To recapitulate
native cartilage structures (e.g., different regions of cartilage, the osteochondral
interface), multi-layer hydrogels incorporating several fabrication techniques can also be
utilized (bottom).
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3.3.1. HYDROGEL FIBERS
Fiber fabrication techniques at length scales ranging from 150 nm to 1600 µm
are typically generated by either spinning or 3D printing. The resultant fibrous networks
offer a number of potential advantages, from more facile cell infiltration and greater
hydrogel surface area (and thus improved diffusion of nutrients and other soluble
factors) to increased mechanical properties. The techniques involve both the
encapsulation of cells within macro-fibers to the seeding of meshes formed from
nanofibers. Numerous groups have engineered hydrogel fibers using material
composites and copolymers that allow for subsequent photo and ionic crosslinking,
resulting in a wide spectrum of material properties.
3D printing, or additive manufacturing, typically involves the building of 3D
structures layer-by-layer with the controlled deposition of materials. A chief concern with
3D printing of cell-laden hydrogels is the optimization of print parameters and control
over material properties to enable efficient printing while preserving cell viability and
phenotype. Schuurman et al. adapted a methacrylated gelatin formulation by introducing
HA to increase the viscosity of the precursor material and demonstrated print fidelity and
chondrocyte viability with post-print photocrosslinking.41 Conceptually similar fabrication
techniques have been explored with other methods, including the use of ionically
crosslinkable materials in lieu of photocrosslinking. For example, Fedorovich et al. used
chondrocyte-laden alginate crosslinked with calcium chloride.42 In this case, constructs
were printed with varying nozzle diameter, print speed, and fiber orientation and then
cultured or implanted subcutaneously to demonstrate cell viability and tissue formation.42
Building upon this approach, Markstedt et al. engineered additional shearthinning properties into this ionically crosslinkable network by incorporating nanofibrillar
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cellulose into the alginate precursors to give the material additional shear-thinning
properties.43 Cui et al. examined the timing of crosslinking in this context as well,
demonstrating direct 3D printing into osteochondral defects using a PEG dimethacrylate
(PEGMA) hydrogel in an explant model.44 The authors found greater chondrocyte
viability and more uniform cell distribution with tandem (simultaneous) crosslinking,
where crosslinking occurs at the same time as gel extrusion, rather than with traditional
post-print crosslinking in which the construct can be crosslinked after printing.44
Thermally responsive hydrogels use temperature to modulate their gelation
behavior, allowing for the transition from liquid to a hydrogel as a function of temperature
exclusively. This is particularly appealing in cartilage tissue engineering, since the
change from ambient temperature to physiological conditions can induce rapid gel
formation45 or stabilize materials in 3D printing processes. A common composite choice
for thermoresponsive “bioinks” consists of HA or chondroitin sulfate mixed with a
thermoresponsive polymer. Numerous groups have tested different thermoresponsive
materials in this regard, from poly(N-isopropylacrylamide) (pNIPAAM)46 to triblock
copolymers composed of PEG linked to N-(2-hydroxypropyl) methacrylamide (HPMA).47
In exploring possible effects of thermoresponsive material structures at the
nanoscale, Muller et al. showed that nanostructuring a thermoresponsive hydrogel
allowed for high chondrocyte viability in a printed multilayer mesh and other more
physiologically-relevant constructs including an ear (Figure 3.4e) and a sheep meniscus
(Figure 3.4f-g).48 In this case, the authors incorporated both unmodified and acrylated
Pluronic, crosslinked, and then subsequently washed out the unmodified fraction. In
each case mentioned, methacrylated HA or chondroitin sulfate was either used as a
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crosslinker or as an independent reinforcing network to compensate for the generally
poor mechanics of the thermoresponsive component.
A number of techniques that use spinning technology have been explored
towards fabricating hydrogel fibers. A wet-spinning technique was introduced by Han
and colleagues in which an 8-arm methacrylated PEG precursor was injected through a
syringe pump into a tris(2-aminoethyl) amine (TAEA) bath.50 Subsequent crosslinking
yielded microribbons that could be further crosslinked together to form hydrogels with
complex geometries at both the micro and macro scales, and these hydrogels supported
adipose-derived stem cell viability as well as proliferation and spreading under various
conditions with the potential of recapitulating the laminar matrix organization of cartilage
tissue.50

Figure 3.4. Examples of hydrogel scaffold processing. SEM micrographs of PBLG
microsphere hydrogels fabricated at a gelatin concentration of (a,b) 1.9 % and (c,d) 3.25
%.49 3D printing was used to print (e) a human ear and (f,g) sheep meniscus, as seen
from different angles with Ink8020 after crosslinking.48

Electrospinning has also been used to generate fibrous constructs from
methacrylated HA that supported human MSC interactions and chondrogenesis, without
outcomes dependent on the hydrogel fiber properties such as mechanics and
adhesion.51 Multi-polymer fibrous scaffolds were fabricated using HA hydrogels and
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implanted in combination with microfracture for tissue repair in a mini-pig model. The
multi-polymer design allowed for stable fibers to maintain the fiber structure and
degradable fibers to release chondroinductive factors. Here, the transforming growth
factor beta 3 (TGF-β3) spun into degradable HA fibers was verified to be active upon
release, and in vivo it resulted in improved histological scores and type 2 collagen
content in the repaired defects.52 Fiber spinning and printing have also been combined in
cell-laden constructs, where, for instance, alternating rounds of electrospinning of
polycaprolactone (PCL) fibers and printing of fibrin-collagen hydrogels were performed
to yield scaffolds with greater mechanical properties and improved histological staining
of GAGs and type 2 collagen in 8-week subcutaneous implant studies in mice.53

3.3.2. POROUS HYDROGELS
While hydrogel fibers and scaffolds comprised of fibrous networks permit the
incorporation of pores of varying shapes and sizes, several other methods for generating
porous hydrogel constructs within the context of cartilage tissue engineering also exist.
These may be advantageous in some cases since they do not need specialized printing
or spinning equipment and may produce scaffolds more rapidly. More recently, the
design of porous hydrogels has turned to dynamic control of macroporosity as well as
dynamic control of bulk material properties.
Han et al. developed stimuli-responsive porogens from alginate, gelatin, and HA
that respond to chelation, temperature, and enzymatic activity.54 Here, the alginate
porogen was also used to deliver chondrocytes into the hydrogel, and treatment with
changes in temperature, EDTA, or hyaluronidase activity released chondrocytes from
the alginate components and subsequently increased hydrogel macroporosity.54 While
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this controlled degree of macroporosity affected bulk mechanical properties, approaches
have also been developed where mechanics can be dynamically increased with
photocrosslinking, such as from 2.6 to 12.5 kPa, without changing porosity.55 In this
case, across the range of mechanics tested, chondrogenic gene expression by human
MSCs in porous constructs was slightly upregulated even in the absence of
chondrogenic media.55 In a different approach, Ahrem et al. treated whole bacterial
nanocellulose hydrogels with 3D laser perforation to produce a porous construct that
promoted chondrocyte ingrowth and proliferation.56 Control of hydrogel porosity and
functionalization of pore interiors with relevant molecules such as type II collagen have
also been explored in tandem with the use of stimuli-responsive materials. For example,
Almeida et al. recently showed that “shape-memory” properties can be attained by
covalent crosslinking of alginate scaffolds by making use of carbodiimide chemistry,
which along with type II collagen incorporation led to higher sulfated GAG (sGAG) and
collagen production in comparison to scaffolds functionalized with type I collagen.57
As a complement or alternative to porous bulk hydrogels, scaffolds comprised of
microspheres from a range of materials have also been developed. Such scaffolds have
been studied most often as delivery vehicles or depots for small molecules or proteins,
but they have also been used as potential cell carriers (i.e., cell microencapsulations). In
one case, a xanthan gum derivative was selected as the encapsulation material because
of its established safety record in pharmaceuticals, food, and cosmetics, as well as its
observed protective effects on joint cartilage via an intra-articular injection.58,59 Murine
chondrocytes were viable in these microgels as observed for up to 21 days.60 Another
interesting scaffold comprised of the synthetic peptide poly(g-benzyl-L-glutamate)
(PBLG) achieved tunable porosity in microspheres by varying amounts of gelatin
porogen followed by its removal, producing spherical hydrogel scaffolds that could be
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seeded with chondrocytes throughout their interior (Figure 3.4a-d); in vitro, they retained
chondrocyte roundness after seeding and supported ECM deposition in culture for 3 to 7
days, and when injected subcutaneously in vivo they formed tissue with improved
histological scoring and type 2 collagen content compared to cell-only injections.49
3.3.3. MULTILAYERED SCAFFOLDS
The final scale of architectural complexity in cartilage engineering is one that
attempts to recapitulate the zonal architecture of cartilage in the joint. Regardless of the
particular technique used to deposit or arrange the material, numerous groups have
worked

to

establish

two-to-three-layered

hydrogel

constructs

with

differential

characteristics to mimic the zones likely damaged by osteochondral defects. Feasibility
of a 3D printed bilayer hydrogel construct has been demonstrated, both by 3D extrusion
of material44 and by projection stereolithography.61 As for trilayer hydrogels, Nguyen et
al. described a PEG-based hydrogel with the superficial layer containing chondroitin
sulfate and an matrix metalloproteinase (MMP)-sensitive peptide, the middle layer
containing PEG and chondroitin sulfate, and the deep layer composed of PEG and HA.62
In such a construct the investigators showed that with a single stem cell population
evenly distributed in all layers, type II collagen deposition decreased gradually from
superficial to deep layers along with an increase in type X collagen and proteoglycans,
resulting in a gradient of compressive modulus across the construct.
With all of this said, there are a number of different approaches to zonal design
of hydrogel constructs, with alternatives including the use of different cell types (e.g.,
chondrocytes, osteogenic progenitors)42 or culture conditions in each layer rather than
substantially modifying the material characteristics of the layer itself. It remains to be
seen how advances in the design of hydrogels with this degree of control over
52

architecture will compare with other diverse strategies for hydrogel engineering towards
cartilage repair.
3.4. CONTROLLED PRESENTATION AND DELIVERY OF BIOCHEMICAL FACTORS
Cartilage formation is regulated by the dynamic spatial and temporal presentation
of an assortment of biochemical factors that either interact with receptors at the cell
surface, or are internalized by cells, resulting in the induction of chondrogenesis. Thus,
hydrogels are being designed with both biomolecules that are directly tethered to the
hydrogel and those that are released to encapsulated or surrounding cells. This control
over biomolecule spatial introduction and timing can aid in the production of
heterogeneous constructs to mimic developing or adult tissues and to enhance the
dynamic processes of differentiation.
The spatial and temporal presentation of biochemical factors is extremely
important, since uncontrolled exposure may not only reduce effects on chondrogenesis
and cartilage formation, but can also induce adverse effects. For example, supraphysiological levels of TGF-β delivered via injections to murine knee joints resulted in a
decrease in proteoglycan synthesis, synovial fibrosis, and endochondral ossification.63,64
To regulate the magnitude and timing of biochemical factors that interact with cell
surface receptors, several techniques including protease-degradable tethers and
presenting factors in their latent form65,66 have been recently proposed. To achieve
controlled release of cartilage-inducing factors that are internalized by cells, novel design
techniques towards the improved design of carrier vehicles (e.g., microparticles (MPs) or
nanoparticles (NPs)) loaded with biochemical factors have been proposed. In this
section we will highlight several recent advances of biochemical factor presentation
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using these mechanisms and their in vivo and in vitro cartilage regeneration potential
using cell-laden and acellular hydrogels (Figure 3.5).

Figure 3.5. Overview of controlled presentation of biochemical factors. These
include cell-cell and cell-matrix interactions, as well as growth factors and other
molecules that can be either tethered to the hydrogels via affinity or heparin binding, or
encapsulated in MPs and NPs for controlled release.

3.4.1. COVALENT CONJUGATION AND AFFINITY BINDING OF BIOCHEMICAL
FACTORS
In order to present cells with biochemical cues that interact with integrins or receptors at
the cell surface, these signals are typically incorporated into the hydrogel itself, either by
covalent tethering or affinity binding via electrostatic interactions as is observed within
the ECM. Chemical coupling of peptides to hydrogels is one of the simplest approaches
that can be taken to modify hydrogels with biochemical signals.
During limb development, the first instance of cartilage formation occurs within a highly
condensed cell-rich aggregate that is largely devoid of ECM.67 Cell-cell interactions in
this context are mediated by the adhesion molecule N-cadherin68,69,70 and these
54

interactions regulate signaling events that are critical to the initiation of chondrogenesis.
Of note, these cell-cell adhesion signals are not present throughout development, but
rather arise and peak during this condensation phase, after which adhesion-based
signaling from the formed ECM dominates.71 To this end, Bian et al. recently developed
an HA hydrogel system that incorporates an N-cadherin mimetic peptide (i.e., HAV)
(Figure 3.6a), and found that the peptide conjugation promoted both early
chondrogenesis of human MSCs, as well as cartilage-specific matrix production (Figure
3.6b).72 This outcome was even observed in vivo and it was shown recently that the
presence of the N-cadherin signal from the hydrogel also influenced β-catenin signaling
in human MSCs (Figure 3.6c-d).73

Figure 3.6. Influence of N-Cadherin mimetic peptides on MSC chondrogenesis.
Human MSCs were (a) photoencapsulated in hydrogels containing either N-cadherin
mimics or scrambled sequence controls. (b) After 4 weeks of in vitro culture, N-cadherin
mimics enhanced chondroitin sulfate (CS) and type II collagen (COL2) by human MSCs,
as seen by immunohistochemical staining.72 (c-d) Single cell analysis of MSCs in these
hydrogel environments showed an increase in N-cadherin mediated β-catenin signaling
after 3 days in culture. (c) Cross-sectional images of MSCs stained for β-catenin (green)
show that N-cadherin mimics recruit β-catenin to the cell membrane. Additionally, Ncadherin mimics induced an increase in nuclear β-catenin, as confirmed by (d)
representative maximum (top) and average (bottom) projections of single MSCs stained
for actin (red), nucleus (blue) and β-catenin (green).73 Scale bars: b = 50 µm; c,d = 25
µm.
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Due to the importance of the temporal presentation of biochemical signals, there
has been increased interest in regulating the presentation of these biochemical cues via
enzymatic

regulation.

Towards

this,

Salinas

et

al.

used

thiol-acrylate

photopolymerization to tether RGD peptides with an MMP-13 cleavable linker in order to
induce MSCs towards a chondrogenic phenotype.74 The authors found that MSCs
encapsulated in these hydrogels produced active MMP-13 between 9 and 14 days in
culture, resulting in an over ten-fold increase of GAG deposition in comparison to MSCs
exposed to non-cleavable RGD peptides.74
Besides peptides, growth factors, such as those from the TGF-β superfamily
have also been tethered to hydrogels. Although TGF-β plays a key role in promoting
chondrogenesis, its therapeutic utility is limited by its inherent protein instability, requiring
high amounts of protein that can cause adverse side effects with inefficient cartilage
formation. Choi and coworkers compared hydrogels containing TGF-β1 covalently
tethered

to

visible

blue

light-inducible

chitosan

(MeGC)

hydrogels

prior

to

photopolymerizing with type II collagen versus MeGC hydrogels with positively-charged
TGF-β1 ionically conjugated to type II collagen.75 The authors found that the cumulative
release of TGF-β1 was significantly higher in the covalently bound system, resulting in
more sGAG production by adipose-derived stem cells in vitro, as well as improved
integration with surrounding tissue of hydrogels implanted in a rat cartilage defect
model.75
In vivo, control over the bioavailability of biomolecules is dependent on numerous
factors. For example, growth factors including TGF-β are present as a complex which
includes a latency associated peptide (LAP), which inactivates TGF-β by masking the
receptor-binding domains.76 As such, members of the TGF-β superfamily remain inactive
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and protected from degradation until LAP is removed by one of several mechanisms
including proteolytic cleavage of LAP. Place et al. sought to recapitulate this natural
mechanism by coupling TGF-β1 in its latent form to PEGDA prior to crosslinking with
thiolated HA hydrogels via a Michael addition reaction.65 The authors found that
encapsulated chondrocytes in these hydrogels were viable for up to 34 days and
produced type II collagen without the presence of soluble TGF-β1, as confirmed by
immunocytochemistry.65
In addition to covalent conjugation, affinity binding of macromolecules to growth
factors is an alternative method towards the controlled release of growth factors. To this
end, dendrimers, a particular type of branched macromolecules, can be functionalized
with peptides that selectively bind to different molecules.77 Seelbach et al. recently
investigated the use of dendrimers with affinity binding peptides towards the non-burst
release of bone morphometric protein 2 (BMP-2) and TGF-β1.78 Briefly, dendrimers
containing four binding peptides presenting sequences targeting BMP-2 or TGF-β1
protein

binding

were

covalently

conjugated

to

HA,

mixed

with

poly(N-

isopropylacrylamide)-grafted HA (Hyal-pN) brush copolymers, and then loaded with
BMP-2 or TGF-β1. The authors found a dependence on the release of these growth
factors based on the length of the dendrimer arms.
GAGs are highly negatively charged polysaccharides that can modulate
macromolecular binding, particularly with positively-charged molecules.79 By regulating
the degree of GAG sulfation, the extent of this charge can be tuned to control the
presentation of positively-charged growth factors (e.g., TGF-β1). To this extent, Lim et
al. showed that MSCs cultured in TGF-β1 containing media and encapsulated in
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desulfated chondroitin hydrogels featured significantly upregulated gene expression of
type II collagen and aggrecan when compared to a PEG-based control hydrogel.80

3.4.2. PARTICLES FOR CONTROLLED RELEASE OF BIOCHEMICAL FACTORS
Carrier vehicles such as MPs and NPs as a method to deliver encapsulated
factors have been extensively studied and optimized to achieve continuous delivery of
their payload by controlling the chemical (e.g., charge, degradability) and physical (e.g.,
carrier size, shell thickness) properties of the carriers. In contrast to simple diffusion of
soluble cues into hydrogel constructs, loaded MPs encapsulated in hydrogels protect
biochemical factors from degradation and help prevent rapid diffusion and clearance
from hydrogels, allowing for greater control over the release kinetics of biochemical cues
into the hydrogel. Although this technique has been used and investigated for decades,
the utility of MPs81,82 and NPs83-86 has seen recent advances in the use of delivery
vehicles for cartilage repair.
To achieve a more sustained delivery of growth factors, Spiller and coworkers
recently designed a hybrid scaffold where insulin-like growth factor 1 (IGF-1) was loaded
into a poly(vinyl alcohol) (PVA) and poly(lactic-co-glycolic acid) (PLGA) hydrogel
system.87 The authors here used a novel double emulsion technique such that PLGA
MPs (11.3 ± 6.4 µm) containing IGF-1 directly formed and evenly dispersed throughout
the PVA hydrogel. The authors showed that the IGF-1 release was linear and sustained
for at least 45 days, and in vivo studies showed that the hydrogel resulted in the
formation of thick cartilage layers and exhibited good integration between the formed
cartilage and the surrounding neocartilage.
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In addition to IGF-1, there are other biochemical cues that enhance cartilage
formation and can benefit from a suitable delivery vehicle for their sustained release.
Nell-like molecule 1 (Nell-1) has previously been shown to induce differentiation and
growth towards bone and cartilage tissue in vivo.88 In order to showcase the importance
of sustained release of Nell-1, Siu et al. compared the release of Nell-1 from alginate
hydrogels either directly encapsulated in the bulk hydrogel, or loaded into chitosan NPs
(100 – 300 nm in size).85 The authors found that Nell-1 containing NPs induced a
significantly more gradual release of the protein in comparison to hydrogels where Nell-1
was directly encapsulated. Additionally, Nell-1 NP containing hydrogels induced an
increase in GAG synthesis and proteoglycan accumulation in a critical size
osteochondral defect 12 weeks post-implantation.85 This study showed not only the
importance of Nell-1 in cartilage formation, but also the need for NPs for controlled
release.
Although design parameters used to control the release kinetics of biochemical
factors loaded in MPs and NPs have been thoroughly investigated, not much work has
been done to study the influence of the encapsulating hydrogel on the release profiles of
biochemical cues loaded in MPs and NPs. To this end, Ahearne and coworkers studied
how different hydrogel macromers (i.e., fibrin, agarose, and gellan gum) affected the
efficiency of TGF-β3 loaded MPs to induce chondrogenesis of encapsulated MSCs.
Piglet MSCs and TGF-β3 loaded gelatin MPs (50 – 70 µm) were encapsulated in fibrin,
agarose, or gellan gum hydrogels, and the role of the MPs in inducing cartilage
formation from the MSCs over the course of 21 days in vitro was evaluated.89 The
authors observed a significant increase in sGAG accumulation in the agarose and gellan
gum hydrogels in comparison to the fibrin hydrogels. Additionally, histological staining
with alcian blue showed a stronger and more homogeneous distribution of sGAG in the
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gellan gum hydrogels, in contrast to a more pericellular presentation of sGAG in the
agarose hydrogels. This study shows that not just MPs and NPs, but the hydrogel
macromers as well, are important determinants of the release profiles of biochemical
factors loaded in these vehicle carriers.

3.5. CONCLUSIONS
Although hyaline cartilage is perceived as a simple tissue, developing
biomaterials that can achieve mechanical properties of native cartilage and complete
integration with surrounding tissues remains a challenge. Cartilage tissue engineering
has seen a rapid advance in fabrication techniques that have resulted in hydrogel
constructs that are improving the quality of produced cartilage (summarized in Table 1).
To increase the mechanical properties of hydrogels, traditional single network hydrogels
are being supplemented with either additional networks or mixtures of polymers. These
techniques have also been used to fabricate hydrogels which can induce integration with
surrounding tissue while promoting chondrogenesis in vivo. Novel processing techniques
have also been employed towards fabricating hydrogel fibers and porous hydrogels for
improved cartilage formation, as well as the fabrication of multilayered hydrogels that
mimic the zonal architecture of native cartilage. In addition to these advances, the field
has also seen an increased interest in presenting biochemical cues in a controllable and
temporal fashion.
Looking ahead, combinatorial screening approaches to robustly identify
synergies between the various hydrogel parameters presented in this review would
enable the development of cell-laden and acellular hydrogels that will eventually
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adequately recapitulate native cartilage. The technology to achieve this kind of screening
has been explored for the discovery of hydrogels with a variety of properties such as gel
tearing energy, cell adhesion and proliferation, and foreign body responses.90-93 So far
this has been achieved by changing the extent of material modification, the combinations
of different materials at different ratios, or the amount of a peptide of interest in the
precursor. Although none of these types of combinatorial hydrogel platforms have been
directly applied to probe chondrogenesis or cartilage matrix synthesis, they are
extremely promising for this application. Additionally, a better understanding of cartilage
both during development and in its mature state will be critical to the success of
advancing these exciting techniques towards developing hydrogel systems that robustly
recapitulate native cartilage. Ultimately, as technology is developed with new polymers
synthesized and new processing techniques advanced, this field will continue to expand.
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Improvements in hydrogel structure
IPNs

(Dinescu et al., 2015; Guo
et al., 2012; Ingavle et al.,
2013; Snyder et al., 2014)

Semi-IPNs

(Little et al., 2014; Park et
al., 2013; Skaalure et al.,
2014)
(Arnold et al., 2011;
Kitamura et al., 2016)

Double
networks
Dual
networks
Guest-host
networks

Mimetic
peptides
MPs / NPs
ECM affinity
binding

(Jin et al., 2011; Levett et
al., 2014; Moreira Teixeira
et al., 2012; Palumbo et al.,
2015; Pirinen et al., 2015)
(Jung et al., 2014; Wei et
al., 2016)

Advances in the processing of
hydrogel scaffolds
3D printing
(Fedorovich et al.,
2012; Kesti et al.,
2015; Markstedt et
al., 2015; Muller et
al., 2015; Schuurman
et al., 2013)
Spinning
(Han et al., 2014; Xu
et al., 2013)
Porosity
Microspheres

(Ahrem et al., 2014;
Han et al., 2013;
Marklein et al., 2012)
(Fang et al., 2015;
Mendes et al., 2012)

Multilayered

(Cui et al., 2012;
Fedorovich et al.,
2012; Nguyen et al.,
2011; Sun et al.,
2015)
Controlled presentation of biochemical factors
(Bian et al., 2013; Salinas and Anseth, 2008; Vega et al., 2016)
(Ahearne and Kelly, 2013; Siu et al., 2012; Spiller et al., 2012)
(Choi et al., 2015; Seelbach et al., 2015)

Table 3.1. Summary of hydrogel fabrication techniques for cartilage tissue
engineering.
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CHAPTER 4
INFLUENCE OF HYALURONIC ACID MODIFICATION ON CD44 BINDING TOWARDS
THE DESIGN OF HYDROGEL BIOMATERIALS

4.1. INTRODUCTION
Hyaluronic acid (HA) is a linear hydrophilic polysaccharide of alternating Dglucuronic acid and N-acetyl-D-glucosamine that is abundant in a variety of tissues and
is relevant in both development and wound healing.1 Cells interact with HA via surface
receptors, including the primary receptor CD44.2 Interactions between CD44 and HA
occur within the HA-binding domain (HABD, often 25-174aa), which is well-conserved
across species, and reportedly requires a minimum of a 6-mer (hexasaccharide, or 3 HA
repeat units) and optimally an 8-mer (octasaccharide, or 4 HA repeat units) for binding.3
CD44 is understood to play a critical role in pericellular matrix assembly, retention, and
organization, and its function is required for a range of cellular processes including
morphogenesis, proliferation, and wound repair.1 CD44 is widely expressed on a variety
of cell types, including mesenchymal stromal cells (MSCs).4
HA lends itself to numerous biomedical applications due to these cellular
interactions and its presence and role in the extracellular matrix of many tissues.5
Applications include drug delivery and tissue bulking and some HA-based materials are
already well established in the clinic (e.g., dermal fillers and viscosupplements).6-11 HA
hydrogels have also been widely explored in tissue engineering, particularly as cell
carriers where properties such as high water content, injectability into tissues,
degradability, and the ability to mimic features of the native extracellular matrix are
important.12-26
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To fabricate hydrogels using HA, HA macromers with chemical modifications that
permit crosslinking are typically synthesized. There are numerous examples of HA
modifications that have enabled covalent crosslinking of HA into hydrogels, including via
Michael addition reactions or photoinitiated radical polymerizations (e.g., acrylates,
methacrylates, maleimides), thiol-ene click reactions that may be performed with spatial
control over crosslinking (e.g., norbornenes), and aqueous Diels-Alder reactions with
furan- and maleimide-functionalized HA macromers.18,27-30 More recently, non-covalent
assembly of HA hydrogels has been achieved via HA modifications that permit physical
interactions, such as with the formation of guest-host complexes (e.g., cyclodextrin and
adamantane, cucurbit[6]uril and diaminohexane) between modified HA macromers.31-33
These modifications involve the addition of pendant groups of varying size, charge, and
hydrophobicity to the HA backbone.
In addition to the types of modifications themselves, the extent of modification
(i.e., the proportion of disaccharide repeats that are modified) can also be controlled
through the synthesis reaction and can be used to alter the crosslink density of the
hydrogel and final material properties. These reactions often target the carboxylic acids
or primary alcohols within HA disaccharides.34,35 Carboxylic acid and primary alcohol
groups are also involved in the interactions between HA and the HA binding domain
(HABD) of CD44 - the carboxylic acid imbues much of the negative charge that is
associated with HA and is reportedly involved in interactions with at least two residues
(Ala102, Ala103) of the HABD, whereas the primary alcohol is involved with at least one
residue (Tyr109) of the HABD.3,36,37 Thus, the hydrophobicity and charge of the final HA
macromer may be influenced not just by the modification introduced but also by where
and how much of it is added to HA.
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One notable target of tissue engineering approaches with HA hydrogels is the
repair of cartilage tissue. Mature articular cartilage is avascular, alymphatic, and cellsparse, and injury typically results in progressive degeneration and ultimately pain and
loss of joint mobility.38 Since HA is abundant in healthy cartilage (e.g., chondrocyte
pericellular matrix) and is involved in cartilage homeostasis, it has been extensively
studied as a component of hydrogels and scaffolds for cartilage repair.16,17,20,23,39-42
Mesenchymal stromal cells (MSCs), which express CD44 as their primary receptor for
HA, are often used together with HA hydrogels.2,43 Prior work has found that MSCs
encapsulated within HA-based hydrogels exhibited greater expression of cartilagespecific markers both in vitro and in vivo when compared to those within inert
polyethylene glycol (PEG) hydrogels.40 Further, the blocking of CD44 with antibodies
abrogated this increased chondrogenesis in HA hydrogels, further implicating CD44 in
MSC-hydrogel interactions.41 This work established that the choice of hydrogel affects
cartilage matrix production and the chondrogenic differentiation of MSCs.
With all of this in mind, there is clear motivation to better understand the
influence of the extent and type of HA modification on its binding to CD44, as well as the
downstream consequences of these interactions on cell behavior (e.g., differentiation of
encapsulated cells). To address this, we modified HA with either norbornenes (NorHA)
or methacrylates (MeHA) to various extents, characterized their interactions with CD44
in a variety of contexts (e.g., soluble form, hydrogel form), and explored the downstream
effects of HA modification on MSC chondrogenesis when encapsulated in HA hydrogels.
PEG was used throughout for comparison as there is no direct binding between CD44
and PEG. Our better understanding of the interactions with CD44 and modified HA
macromers will help in the design of hydrogels for biomedical applications.
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4.2. METHODS

4.2.1. MATERIAL SYNTHESIS
NorHA,

MeHA,

and

PEG-diacrylate

were

synthesized

as

previously

reported.27,27,44 Briefly, to synthesize NorHA, sodium hyaluronate (75 kDa, Lifecore,
Chaska, MN) was converted to HA tert-butyl ammonium salt (HA-TBA) using Dowex
50W proton exchange resin. Frozen and lyophilized HA-TBA was subsequently
dissolved in DMSO and reacted with 5-norbornene-2-methylamine, coupling to either the
carboxylic

acid

using

benzotriazole-1-yl-oxy-tris-(dimethylamino)-phosphonium

hexafluorophosphate (BOP) to make NorHA1 or to the primary hydroxyl using di-tertbutyl
dicarbonate (Boc2O) to make NorHA2. To synthesize MeHA, methacrylic anhydride
(Sigma, St. Louis, MO) was added to HA (75 kDa, Lifecore, Chaska, MN) in deionized
water, and the pH was maintained between 8.0-8.5 with 5 N NaOH, and reacted on ice
for 6 h. Each macromer solution was purified via dialysis (MW cut-off 6–8 kDa) against
deionized water for a minimum of 96 h with 2 changes of water every 24 h. The final
lyophilized HA macromers were characterized using H nuclear magnetic resonance
1

(NMR) and then stored at -20° C (Bruker Advance 360 MHz, Bruker, Billerica, MA;
Figure 4.1). PEG diacrylate (PEG-DA) was synthesized from linear PEG (10 kDa),
acrylated through reaction of PEG-OH (Fluka) with acryloyl chloride and trimethylamine
in dichloromethane. This product was precipitated and then characterized by H NMR
1

(Figure 4.2).
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Figure 4.1. 1H NMR spectra of modified hyaluronic acid (HA). Spectra for low
(~10%), medium (~20%), or high (~40%) modifications of (a) NorHA1 (red), (b) NorHA2
(green), and (c) MeHA (blue).
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Figure 4.2. 1H NMR spectrum of poly(ethylene glycol)-diacrylate (PEG-DA). Spectra
for PEG (10 kDa) modified with acrylates on both ends.

4.2.2. STOCHASTIC MODEL TO ASSESS CD44 BINDING TO MODIFIED HA
Using MATLAB R2016b software, a model was developed and run (n=1000) to
determine the theoretical number of available binding sites for CD44 interactions with
modified HA. In this model, the modification of any HA repeat unit is assumed to
completely inhibit the binding of CD44 due to steric hindrance and/or functional group
hydrophobicity/charge. Stochastic conversion of HA repeats was assumed for the
conjugation of pendant groups to HA. Given a minimum of four (non-functionalized) HA
repeat units in a row required per CD44 binding event, the distribution of binding site
availabilities along a single 75 kDa HA chain was computed for low (10%), med (20%),
and high (40%) extents of modification.

4.2.3. CD44 PLATE ASSAY
Protein G coated plates (Thermo Fisher Scientific, Waltham, MA) were treated
with recombinant human CD44 Fc chimera protein (1 µg/mL, R&D, Minneapolis, MN)
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and subsequently covalently crosslinked using bis(sulfosuccinimidyl) suberate (1 mM
BS , Thermo Fisher Scientific, Waltham, MA). Macromers modified with FITC-GCKK
3

peptide (1:1 molar ratio, peptide:macromer) were added to wells at 200 µg/mL (HA
backbone concentration, accounting for mass contribution of pendant groups to ensure
constant HA molar amounts across groups) in PBS for 30 minutes. Wells were washed
twice for 2 minutes each and then analyzed for FITC signal using a plate reader (Infinite
M200, Tecan, Männedorf, Switzerland). Values were normalized to the signal for PEG
macromers for reporting.

4.2.4. FLOW CYTOMETRY
To determine the presence of CD44 receptors, human MSCs (Lonza
Walkersville, Inc., Walkersville, MD; original passage number 2) were cultured on tissue
culture plates to 80% confluency and then trypsinized. MSCs were labeled with
Alexafluor 488 conjugated CD44 monoclonal antibody (clone IM7, BioLegend, San
Diego, CA; clone 156-3C11, Cell Signaling, Danvers, MA) for 1 h on ice and analyzed
using flow cytometry (BD FACSCanto II, Becton Dickinson, Franklin Lakes, NJ). To
assess modified HA binding to cell-surface CD44, human MSCs were cultured and
harvested as described above, incubated on ice with FITC-tagged macromers (1:1,
peptide:macromer) at 200 µg/mL, washed twice for 2 minutes each, and then analyzed
for FITC signal using flow cytometry. Values were normalized to the signal for PEG
macromers for reporting.
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4.2.5. HYDROGEL FABRICATION
Macromers were sterilized using a germicidal lamp in a laminar flow hood for 30
min as needed. NorHA1 and NorHA2 were dissolved in sterile phosphate buffered saline
(PBS) containing 0.05 wt% 2-methyl-1-[4-(hydroxyethoxy)phenyl]-2-methyl-1-propanone
(Irgacure 2959, I2959, Ciba, Basel, Switzerland) and DL-dithiothreitol (DTT, Millipore
Sigma) for polymerization, while MeHA and 4-arm PEG maleimide (purity >90%, Jenkem
USA) were dissolved in a solution of PBS containing DTT (all concentrations of HA
macromers calculated to account for mass contribution of pendant groups, thus ensuring
constant HA molar amounts across groups). NorHA1 and NorHA2 were reacted with
DTT via a light-mediated thiol-ene addition reaction between norbornene groups and
thiols with ultraviolet light (Eiko, 1.9 mW/cm , Topbulb, East Chicago, IN) for 10 min to
2

produce crosslinked NorHA hydrogels. MeHA and PEG were reacted with DTT via
Michael-type addition by the addition of triethanolamine (TEOA) buffer to pH 8 to yield
MeHA and PEG hydrogels, respectively.

4.2.6. HYDROGEL CHARACTERIZATION
Acellular hydrogels (2 wt%, ~5 mm in diameter and 1 mm thick) were tested in
unconfined compression using a Dynamic Mechanical Analyzer Q800 (DMAQ800, TA
Instruments, New Castle, DE). The weight percent was calculated to account for mass
contribution of pendant groups added to ensure constant HA molar amounts across
groups. Hydrogels were compressed at 0.5 N/min until they reached 70% of their initial
thickness and the modulus was determined as the slope of the stress-versus-strain
curve at low strains (10-20%). Diffusivity measurements were performed on a confocal
microscope (TCS SP5, Leica, Wetzlar, Germany) using a fluorescence recovery after
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photobleaching (FRAP) technique. Hydrogels containing 100 µM soluble FITC-dextran
(average molecular weight 150 kDa) were placed on glass slides and covered with a
glass cover slip; the 488 nm line of an argon laser was set to 50% power and images
were captured at 10x with the pinhole fully opened. Pre-bleach images were recorded
over 6 seconds using 0.1% transmission. A 30µm diameter circular region was bleached
for 30 seconds at 100 % transmission, and post-bleach images were then captured at
0.1 % transmission for 120 seconds (Figure 4.3, 60s recovery shown). Data was
analyzed using a custom MATLAB script that fit recovery profiles using nonlinear least
squares regression to the Soumpasis equation:

(1) where F(t) is the normalized fluorescence recovery profile, k is the mobile fraction, τ

D

represents the characteristic diffusion time (s), t represents time (s), and I and I are zero
0

1

and first order modified Bessel functions of the first kind. Effective diffusivities were then
calculated according to:

(2) where D is the effective diffusivity (µm /s) and w represents the bleach spot radius
eff

2

(µm). This protocol was adapted from prior studies that conducted similar analyses.45
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Figure 4.3. Fluorescence recovery after photobleaching in hydrogels. Hydrogels
containing FITC-dextran (150 kDa) were imaged at 4 second intervals to assess the
effect of HA modification on relative diffusivity. Representative images shown for
NorHA1 at low modification.

4.2.7. CD44 ATOMIC FORCE MICROSCOPY
Atomic

force

microscopy

(AFM)

was

performed

using

custom

CD44-

functionalized beads on cantilevers. Briefly, protein G coated polystyrene beads (mean
diameter 3.4±0.7 µm, Spherotech, Lake Forest, IL) were treated with recombinant
human CD44 Fc chimera protein (1 µg/mL, R&D, Minneapolis, MN), which was
covalently crosslinked using bis(sulfosuccinimidyl) suberate (1 mM BS , Thermo Fisher
3

Scientific, Waltham, MA). CD44-coated beads were washed in deionized water twice for
2 minutes, plated on glass, dried, and affixed to tipless silicon SPM-sensors (Arrow TL1,
nominal spring constant 0.03 N/m, NanoAndMore). Hydrogels fabricated from
macromers were probed with these custom CD44 bead tips in indentation testing at 10
µm/s with zero dwell time and 1.2±0.9 µm maximum indentation depth, and the
maximum deflection from baseline in the output retraction curves were used to calculate
retraction forces on the cantilever.

4.2.8. CELL ENCAPSULATION
Human MSCs were encapsulated at a density of 20 x 10 cells/mL in 2 wt%
6

hydrogels (weight percent calculated to account for mass contribution of pendant groups
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added to ensure constant HA molar amounts across groups). MSC-laden hydrogels
were cultured in chondrogenic media (DMEM, 1% v/v ITS+ Premix, 50 µg/ml L-proline,
0.1 µM dexamethasone, 0.9 mM sodium pyruvate, 50 µg/mL ascorbate, 1% v/v
penicillin-streptomycin, supplemented with 10 ng/mL TGF-β3). For viability analysis,
human MSCs encapsulated in hydrogels were stained using a Live/Dead® cell viability
assay (Invitrogen) according to the manufacturer’s instructions and viability was
quantified as the ratio of calcein-AM-stained cells to the total cell count.
4.2.9. CHONDROGENIC GENE EXPRESSION
After 3 days in culture, samples were homogenized in Trizol (Invitrogen) using a
handheld tissue homogenizer. RNA was extracted according to manufacturer protocol
and measured using an ND-1000 spectrophotometer (Nanodrop Technologies). 1 µg
RNA from each sample was used for cDNA synthesis using reverse transcriptase
(Superscript II, Invitrogen) and random hexamers as the primers (Invitrogen).
Polymerase chain reaction (PCR) was then performed using the Applied Biosystems
7300 system for Real-Time PCR with a 25 µL reaction volume for Taqman (5′-nuclease)
and SYBR Green reactions (n = 4). Primers and probes for relevant targets
glyceraldehyde 3-phosphate dehydrogenase (GAPDH, housekeeping gene), type I
collagen (COL1A1), type II collagen (COL2A1), aggrecan (ACAN), and sox9 (SOX9)
were selected (Table 4.1). Relative gene expression was assessed using the ΔΔCT
method, where the fold difference is 2−ΔΔCt.
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Table 4.1. Primer and probe sequences used for quantitative PCR.

4.2.10. BIOCHEMICAL AND HISTOLOGICAL ANALYSIS
MSC-laden hydrogels were cultured for 8 weeks and subsequently digested
using papain (1 mL/construct, 0.56 U/mL in 0.1 M sodium acetate, 10 M cysteine
hydrochloric acid, and 0.05 M ethylenediaminetetraacetic acid) at pH 6.0 and 60 °C for
16 h. Samples were then analyzed for the presence of sulfated glycosaminoglycan
(using

dimethylmethylene

(orthohydroxyproline,

using

blue),

DNA

(using

PicoGreen),

dimethylaminobenzaldehyde

and

and

chloramine

collagen
T),

as

performed previously.42 For histological analysis, samples were fixed in 10% formalin (24
h), embedded in paraffin and subsequently stabilized at 4 °C (24 h), and processed
using standard histological protocols. Histological sections (8 µm) were stained using
antibodies for type I collagen (Col I, mouse monoclonal anticollagen type 1, Millipore),
type II collagen (Col II; mouse monoclonal anticollagen type II, Developmental Studies
Hybridoma Bank), and sulfated glycosaminoglycan (alcian blue, pH 1.0). For
quantification, images were first converted to 8-bit and then inverted; the mean staining
intensity within randomly placed frames for each section was measured with Fiji (Figure
4.4).
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Figure 4.4. Method for quantification of histology and immunohistochemistry.
Images are first converted to 8-bit and then inverted using Fiji. Mean staining intensity is
quantified for each section using a randomly placed frame per section per group (n≥9).

4.2.11. STATISTICAL ANALYSIS
Values are reported as mean values ± the standard error of the mean (s.e.m.).
Transformation and outlier removal were not performed unless otherwise specified.
Normalization was performed for each assay using relevant control groups (e.g., gene
expression was normalized to values for control cells prior to encapsulation).
StatPlus:mac LE (AnalystSoft) was used for statistical analyses with one-way analysis of
variance (ANOVA) (and Tukey’s honestly significant difference post hoc test of the
means) to compare among groups (n ≥ 4), where culture duration and experimental
group were independent factors.

4.3. RESULTS AND DISCUSSION
Despite the widespread use of HA hydrogels in biomedical applications and the
well-documented importance of HA on cell behavior, particularly via cell-surface
receptors such as CD44, few studies have addressed how the modification of HA to form
HA macromers for processing into hydrogels influences receptor binding. Here, we
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aimed to explore the effects of multiple important parameters in the design of HA
macromers on HA-CD44 interactions in both soluble and hydrogel contexts. These
included several types of chemical modifications that have been used in the biomaterials
field, variations in the group on HA that is used for their conjugation, and changes in the
level of modification on HA. We developed a number of novel methods to help quantify
the interactions of CD44 with modified HA, such as atomic force microscopy, and also
investigated how these modifications may influence cell behavior when encapsulated
within HA hydrogels.

4.3.1. DIVERSE MODIFICATIONS OF HA TO FORM HA MACROMERS
To examine the effect of modification of HA macromers on their binding to CD44,
three modified HA macromers were synthesized with expected differences in charge and
hydrophobicity and at three distinct levels of modification (targeting ~10, 20, and 40% of
disaccharides on HA). These included: NorHA1, with HA modified at the carboxylic acid
with norbornenes (low 13.0%, med 20.7%, and high 40.7% modification); NorHA2, with
HA modified at the primary alcohol with norbornenes (9.8%, 19.3%, and 38.9%
modification); and MeHA, with HA modified at the primary alcohol with methacrylates
(12.5%, 19.8%, and 37.1% modification) (Figure 4.5). For all macromers, the difference
between the expected extent of modification and the actual value was 3% or
less. These macromers were identified for this study as they have all been used
previously in cell encapsulation and tissue engineering. Additionally, they can all be
covalently crosslinked into hydrogels using the same crosslinker (here, DTT) to eliminate
any variables that may confound their comparisons.
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Figure 4.5. Hyaluronic acid macromers used to investigate CD44 interactions. (a)
Hyaluronic acid (HA) modified with either norbornenes (NorHA, at either the carboxylic
acid for NorHA1 or primary alcohol for NorHA2) or methacrylates (MeHA). The extent of
modification of HA macromers was quantified using H NMR and categorized as either
low (~10%), medium (~20%), or high (~40%). (b) Theoretical framework for stochastic
modeling of HA modification, where a chain of ~200 disaccharides is modified
stochastically at various rates and the distance between modifications is quantified for
n=1000 simulations. (c) Histogram results from all simulations for the various
modification levels, reported as the number of possible CD44 binding sites per HA chain
based on the need for 4 unmodified disaccharides for binding (vertical dotted line
indicates approximate maximum theoretical number of binding sites per HA chain).
1

The zeta potential of these synthesized HA macromers varied with modification
types and extents - NorHA1 exhibited changes in effective surface charge of up to 45%
with increasing extents of modification, while NorHA2 and MeHA did not show as
pronounced of a trend (Figure 4.6). Additionally, the zeta potentials of MeHA macromers
were closest to that of unmodified HA (approximately 86% of unmodified). Given that the
carboxylic acid within the HA disaccharide lends HA much of its negative charge, it is not
surprising that the zeta potential is markedly altered when this moiety is modified during
synthesis (i.e., NorHA1). The relatively more negative zeta potential of MeHA may be
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attributed to both the retention of the carboxylic acid as well as that methacrylates are
less hydrophobic than norbornenes, which may influence the HA macromers in solution.

Figure 4.6. Extent and type of HA modification alters zeta potential of HA
macromers. Zeta potential for unmodified HA and all HA macromers (red: NorHA1,
green: NorHA2, blue: MeHA) in solution to probe the effect of modification on effective
surface charge. n ≥ 3, ## P < 0.01 relative to PEG control; ** P < 0.01 for groups
indicated.

While it was apparent that modification of HA may alter its charge and
hydrophobicity, we sought to model how this might influence its ability to bind to CD44.
We expected that the number of possible CD44 binding sites along a macromer, defined
here as needing 4 consecutive unmodified disaccharides, would decrease with
increasing extents of modification (Figure 4.5b). Based on this, we developed a
theoretical stochastic model of CD44 binding to modified HA. With this model, assuming
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CD44 molecules would not sterically hinder the binding of other CD44 molecules along
the length of one chain, an unmodified HA molecule that is 75 kDa would theoretically
have 198 disaccharides or approximately 50 binding sites available.
Based on the stochastic model, 10% modification of HA reduces the mean
number of binding sites available per chain to ~ 37 sites (Figure 4.5c). Modifying to
greater extents of 20% or 40% would further reduce the mean number of binding sites
available per chain to ~27 and 11 sites, respectively. Compared to 10% modification,
there would be a decrease of ~27% with 20% modification and a decrease of ~70% with
40% modification. Additionally, the average number of consecutive unmodified
disaccharides is notably reduced with increasing extent of modification, where a high
extent reduces this average value to below the threshold required for binding (Figure
4.7). Although useful to represent potential changes in CD44 binding with HA
modification, this model assumes that modification of a disaccharide unit completely
abrogates binding by CD44, and this may not be true depending on the pendant group
that is used and where on the disaccharide it is attached. For example, a bulky,
hydrophobic pendant group coupled to a moiety that is critical for interactions with CD44
would result in the greatest disruption of binding and more closely approximate the
outputs of this model.
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Figure 4.7. Stochastic models of hyaluronic acid modification. (a) Representative
diagrams of stochastic model output for one HA chain modified to low, med, and high
extents (modification denoted with white circles). (b) Histograms of average number of
consecutive unmodified repeat units (i.e., HA disaccharides) predicted per chain for each
level of modification (n=1000 simulations), where the dotted line indicates the critical
number of repeat units (4 disaccharides) necessary for binding to CD44.

4.3.2. CD44 INTERACTIONS WITH HA MACROMERS IN SOLUBLE FORM
We first characterized CD44 binding to HA macromers in solution to understand
how HA modifications might disrupt interactions with CD44 in the absence of other
factors such as crosslinking. Here, PEG was selected as an inert control molecule that
does not bind CD44. In a first experiment, human CD44 chimera proteins were
covalently linked to protein G-coated surfaces and allowed to interact with modified HA
macromers (Figure 4.8a). Quantification of these interactions between FITC-tagged
modified HA macromers and CD44 indicated that the charge and hydrophobicity of
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modified HA may indeed affect binding to HA. For example, med- and high-modified
NorHA1 macromers were similar to PEG in their binding ability, while all NorHA2 and
MeHA macromers bound several-fold higher than PEG to CD44, with statistical
differences across all modification levels (Figure 4.8b). The greatest changes in binding
were observed with NorHA1, with increased modification resulting in ~38% and ~57%
decreases between modifications of 10-20% and 10-40%, respectively.

Figure 4.8. Modification of HA influences CD44 binding to HA macromers in
soluble form. (a) Protein G-coated plates were treated with a soluble CD44-Fc chimera
for directional presentation of CD44. The plate surface was then exposed to FITCmodified HA macromers and the resulting fluorescent signal was quantified to assess (b)
the influence of the extent and type of modification on CD44-HA interactions (red:
NorHA1, green: NorHA2, blue: MeHA). (c) Human MSCs that express CD44 (shown
through flow cytometry) were exposed to FITC-modified HA macromers and analyzed
using flow cytometry to determine (d) the influence of the extent and type of modification
on interactions between cell-surface CD44 and modified HA (red: NorHA1, green:
NorHA2, blue: MeHA). n=8 for surface measurements and n=3 for flow measurements
per group, dotted lines represent PEG controls, * P < 0.05; ** P < 0.01; ## P< 0.01
relative to PEG control.
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To probe whether this might have implications in terms of actual receptor-ligand
interactions in a cellular context, suspended human MSCs expressing CD44 were
incubated with these same FITC-tagged modified HA macromers and subsequently
analyzed via flow cytometry (Figure 4.8c). Here, high-modified macromers across all
modifications were bound by cell-surface CD44 similarly to PEG, as was the medmodified NorHA1 (Figure 4.8d). In general, macromers with lower extents of
modification bound more greatly to cells. As with the CD44-surface studies, the largest
changes in binding (up to ~50%) with increased modification were observed with
NorHA1 macromers. Importantly, the majority (~63%) of the antibody-binding epitope I/II
(including the HA binding domain) of CD44 on these MSCs are retained after extended
trypsinization to harvest cells from 2D culture, and epitopes that are lost are largely
recovered within 25 minutes (~85%) so that these MSCs are capable of binding HA via
CD44 even after extended trypsinization (Figure 4.9.46 Epitope III (the variable stem) of
CD44 was largely insensitive to extended trypsinization, which agrees with previous
reports (Figure 4.10).47,48
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Figure 4.9. The HA binding domain of CD44 is cleavable by trypsinization but is
largely retained with trypsin treatment. (a) Human MSCs are CD44 and the HA
binding domain of CD44 is susceptible to removal via trypsinization. (b) Cells were
treated with trypsin to harvest them from 2D culture (e.g., for encapsulation) and then
incubated to permit CD44 recovery and/or labeled using a CD44 antibody that binds to
epitope I of CD44. (c) Sample flow cytometry profiles of CD44 epitope I labeling on cells
and (d) normalized means of profile data.
+

91

Figure 4.10. The variable stem region of CD44 is largely insensitive to
trypsinization. (a) Human MSCs are CD44 and the variable stem region of CD44 is
reportedly less susceptible to removal via trypsinization. (b) Cells were treated with
trypsin to harvest them from 2D culture (e.g., for encapsulation) and then labeled using a
CD44 antibody that binds to epitope III of CD44. (c) Sample flow cytometry profiles of
CD44 epitope III labeling on cells and (d) normalized means of profile data.
+

4.3.3. CD44 INTERACTIONS WITH HA MACROMERS IN HYDROGEL FORM
Following characterization of the interactions between CD44 and soluble HA
macromers, we wanted to assess whether the changes in CD44 binding that were
observed in a soluble context also translated to CD44 interactions with hydrogels formed
from crosslinking of the same HA macromers. To investigate this, it was important that
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other features of the hydrogels did not change, so that the only variable being compared
was the modification of HA. We controlled the crosslinking density by using the same
dithiol crosslinker to form all hydrogels of interest via either a thiol-ene (i.e., NorHA1,
NorHA2) or Michael-type addition (i.e., MeHA, PEG) reaction, and all hydrogels were
formed with the same molar concentration of HA. This allowed us to maintain various
hydrogel properties such as the elastic modulus (~5 kPa, Figure 4.11a), mass swelling
ratio (~25, Figure 4.11b), and relative diffusivity (~5 µm /s, Figure 4.11c) across the
2

hydrogels even with different extents and types of modification.

Figure 4.11. Matched properties of HA hydrogels with varying extents and types of
modification. Hydrogels were fabricated from modified HA macromers (red: NorHA1,
green: NorHA2, blue: MeHA) using thiol-ene reactions for NorHA and Michael addition
reactions for MeHA with di-thiol crosslinkers. The same crosslinker concentrations were
used to match properties across modification levels. Hydrogels were analyzed for (a)
elastic modulus (E), (b) mass swelling ratio, and (c) relative diffusivity (D). n=3 hydrogels
per group, dotted lines represent PEG hydrogel controls, n.s. indicates no significant
difference across groups and compared to the PEG hydrogel control.
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To investigate CD44 binding to HA in hydrogel form, a new method was devised
using atomic force microscopy (AFM) to investigate the adhesivity of beads coated with
CD44 to HA hydrogels. The beads were brought into contact with the hydrogels and the
force measured upon retraction was used to assess adhesion, measured as the
maximum adhesion force (Figure 4.12a). Evaluation of this CD44 adhesion to the
hydrogels fabricated from modified HA revealed that, in agreement with findings from the
soluble macromer studies, NorHA1 hydrogels exhibited a downward trend in adhesion
with increasing levels of modification such that a high modification yielded adhesion
forces that were comparable to PEG hydrogels and were ~59% lower than adhesion to
hydrogels from the low modified NorHA1 (Figurd 4.12b). In contrast, although hydrogels
comprised of NorHA2 or MeHA macromers did demonstrate a modest downward trend
in adhesion, adhesion to these hydrogels was still higher than adhesion to PEG
hydrogels, regardless of their extent of modification.

4.3.4. HA MODIFICATION INFLUENCES CHONDROGENESIS IN HYDROGELS
After exploring the effects of HA modification on CD44-HA interactions, we
sought to probe the possible downstream consequences of these effects on outcomes
relevant to tissue engineering. Because NorHA1 most consistently exhibited marked
changes in CD44 binding in the various contexts, we selected this macromer for further
investigation on cell behavior as we would anticipate the large effects at various
modification levels. Human MSCs were encapsulated in 3D hydrogels from the NorHA1
macromers and PEG hydrogels were again used as an inert hydrogel control (Figure
4.13a). Human MSCs demonstrated comparably high cell viabilities (>90%) when
94

encapsulated in 3D NorHA1 hydrogels across the modification levels, as indicated by
live/dead staining (Figure 4.13b). The gross dimensions of the constructs were also
comparable across these groups, which was expected since their levels of crosslinking
and swelling were matched.

Figure 4.12. Modification of HA influences CD44 adhesion to HA hydrogels.
Hydrogels were fabricated from modified HA macromers and characterized using (a)
atomic force microscopy with CD44 modified beads for (b) quantification of adhesion
forces (red: NorHA1, green: NorHA2, blue: MeHA). n ≥ 40 indentations across 3
hydrogels per group, dotted lines represent PEG hydrogel controls, * P < 0.05; ** P <
0.01; ## P< 0.01 relative to the PEG hydrogel control.
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Figure 4.13. Extent of HA modification influences early chondrogenesis in 3D
hydrogels. (a) Human MSCs were encapsulated in HA hydrogels from NorHA1
macromers (red) using a thiol-ene reaction, as well as PEG hydrogel controls (grey).
After 3 days of culture, samples were analyzed for (b) live-dead staining (scale bar 250
µm) and gross appearance of individual specimens (inset scale bar 5 mm), and the
expression of (c) collagen II (COL2), (d) aggrecan (ACAN), and (e) SOX9 genes
(reported normalized to GAPDH and 2D control cells prior to encapsulation). n=4
hydrogels per group, * P < 0.05, ** P < 0.01; # P < 0.05 and ## P < 0.01 relative to the
PEG hydrogel control.
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MSCs expressed COL2A1, ACAN, and SOX9 at 3 days when encapsulated
within hydrogels and incubated in chondrogenic media (Figure 4.13c-e). COL2 and
SOX9 gene expression appeared to decrease with increasing extent of modification,
while ACAN expression did not show a clear trend. Although it represents a nearly 4-fold
difference, SOX9 expression by MSCs in NorHA1 hydrogels with the highest extent of
modification was not significantly greater than the expression levels in PEG; meanwhile,
expression in the presence of low- and med- levels of modification was substantially
higher than in PEG hydrogels (9- and 7-fold, respectively). All constructs showed
relatively little expression of COL1, an undesired marker towards articular cartilage
repair (Figure 4.14). Overall, the expression of all chondrogenic gene expression
markers in NorHA1 encapsulations tended to be higher than that in the PEG controls.

Figure 4.14. The extent of HA norbornene modification does not substantially
increase expression of dedifferentiation marker COL1. Expression of
dedifferentiation marker COL1 in MSCs encapsulated in low-, med-, or high-modification
NorHA1 hydrogels or PEG hydrogel controls at day 3 post-encapsulation. All
measurements normalized to 2D control and GAPDH. n.s. indicates no significant
difference across all groups.

Since cartilage tissue engineering ultimately requires long-term tissue formation
and repair, we also evaluated these constructs in long-term in vitro culture for up to 8
weeks. Here, the influence of HA modification on long-term MSC chondrogenesis
agreed with short-term outcomes, as MSCs encapsulated in NorHA1 hydrogels exhibited
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smaller increases in sulfated GAG (Figure 4.15a) and collagen (Figure 4.15b)
deposition when the NorHA possessed higher levels of modification, as determined by
quantitative biochemical assays. Long-term mechanical properties (Figure 4.15c) of
NorHA1 encapsulations showed modest increases over PEG controls, likely due to
variations in the amount of matrix being produced within the hydrogels (Figure
4.15c). These biochemical levels matched histological findings for glycosaminoglycans
and type II collagen, as shown through semi-quantitative image analysis of histological
sections (Figure 4.15d, 4.16). However, type I collagen was similar across all
groups. Notably, the high level of modification led to similar results to that of the inert
PEG hydrogel controls, implying that the macromer forms hydrogels that act more inertly
rather than with the bioactivity typically considered by using HA in the hydrogel.

Figure 4.15. Extent of HA modification influences long-term chondrogenesis in 3D
hydrogels. Human MSCs were encapsulated in HA hydrogels from NorHA1 macromers
(red) using a thiol-ene reaction, as well as PEG hydrogel controls (grey). After 8 weeks
of culture, samples were analyzed for (a) glycosaminoglycan (GAG) content, (b)
collagen content, (c) compressive modulus, and (d) histological quantification via
staining intensity. n=4 hydrogels per group, * P < 0.05, ** P < 0.01; # P < 0.05 and ## P
< 0.01 relative to the PEG hydrogel control.
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Figure 4.16. Histological assessment of long-term chondrogenesis in 3D
hydrogels. Histological images of alcian blue, type II collagen, and type I collagen
staining (scale bar 250 µm) for MSCs encapsulated in low-, med-, or high-modification
NorHA1 hydrogels or PEG hydrogel controls and cultured for 8 weeks. n≥ 3 hydrogels
per group.

The fact that HA is an important functional component of native cartilage tissue
does indeed make HA-based hydrogels an attractive choice for cartilage tissue
engineering. However, we established that since the carboxylic acid and primary
hydroxyl groups are reportedly involved in interactions with residues in the CD44 HA
binding domain, adding increasing numbers of bulky and hydrophobic pendant groups to
those sites on a given HA molecule may be expected to perturb its bioactivity.37 It is not
surprising, then, that NorHA1, where the carboxylic acid is lost and replaced by a
relatively bulky and hydrophobic norbornene pendant group, showed the greatest
decreases in binding both in solution and in hydrogels. Other modifications showed
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decreased effects on CD44 binding; however, there was still typically a trend with
increasing modification levels.
These findings suggest that early cell interactions with HA in these constructs,
perhaps even starting from the point that cells are introduced into solutions of the
macromers prior to crosslinking, may be altered by the extent and type of modifications
made to the macromers used. Interactions between CD44 and HA appear to help drive
expression of cartilage-specific markers, where expression of CD44 itself even increases
during chondrogenesis; with this in mind, it would be expected that high extents of
modification that perturb CD44-HA interactions would have the greatest effects on
downstream matrix deposition and tissue formation, and our results appear to agree well
with this.49 Interestingly, however, NorHA1 still enhanced both short- and long-term
chondrogenesis relative to PEG even at 20% modification, and this may suggest that
even for bulkier hydrophobic pendant groups added to the carboxylic acid moiety in
synthesis, there is a permissive window of modification where some level of the
bioactivity of HA is preserved.

4.4. CONCLUSIONS
In summary, CD44-HA interactions can be altered when HA is modified to
synthesize HA macromers, with alterations dependent on the extent of modification, type
of chemical group used for modification, and the site on HA used for modification. These
effects are observable when the HA macromers are presented to CD44 both in soluble
form or after crosslinking into hydrogels. Gene expression and long-term biochemical
and histological analyses of MSCs encapsulated in HA hydrogels strongly suggest that
modification levels of the HA macromer influences cell-hydrogel interactions and
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chondrogenic differentiation. Generally, a more hydrophobic pendant group attached to
a more critical moiety for CD44 binding (e.g., charged acid) on the HA backbone can
have marked effects on CD44-HA interactions. Importantly, low and moderately modified
HA hydrogels still promoted significantly greater binding to CD44 when compared to
inert molecules and upregulated chondrogenesis and cartilage formation were observed
in HA hydrogels when compared to inert PEG hydrogel controls. We suggest that these
considerations be incorporated into the design of HA hydrogels for tissue engineering
with their significance dependent on the application and importance of CD44 binding.
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CHAPTER 5
MAGNITUDE AND TIMING OF N-CADHERIN MIMETIC PEPTIDE PRESENTATION
REGULATE MSC CHONDROGENESIS WITHIN HA HYDROGELS

Adapted from:
Kwon MY, Vega SL, Gramlich WM, Kim M, Mauck RL, Burdick JA. Dose and Timing of
N-Cadherin Mimetic Peptides Regulate MSC Chondrogenesis within Hydrogels. Adv
Healthc Mater. 2018;7:e1701199.

5.1. INTRODUCTION
Human mesenchymal stem cells (MSCs) have gained widespread use as a cell source
for tissue engineering applications due to their clinical relevance and multipotency.1,2 As
our understanding of the native cell microenvironment expands, this information can be
incorporated into the design of tissue-engineered constructs to control MSC
differentiation. To this end, a variety of soluble, tethered, and physical considerations
have been incorporated into the design of hydrogels, and prior works have explored the
effects of combinations of these factors on MSC chondrogenesis; however, although the
physical nature of hydrogels has become more dynamic, e.g. with cell-mediated
degradation of crosslinkers to match matrix deposition, investigating the dynamic nature
of the biological aspects of hydrogels remain a challenge.3-8
Hyaluronic acid (HA) has emerged as one of the most studied biomaterial components
for cartilage tissue engineering.8,9 HA is a linear polysaccharide (a non-sulfated
glycosaminoglycan, or GAG) that is part of the nascent extracellular matrix (ECM) in
tissues such as cartilage and is present during the condensation phase of limb bud
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development in the embryo.10,11,12 Cellular interactions with HA are mediated via its
principal cell-surface receptor CD44 along with others such as CD168 (Rhamm), which
induces chondrogenic differentiation via nuclear Smad translocation.13,14 HA hydrogels
are widely known to support improved matrix synthesis by chondrocytes and
chondrogenic differentiation of MSCs over typical inert materials.15,16 Importantly, HA
disaccharide repeat units can be easily functionalized, and this has been exploited for
not only crosslinking of HA, but for the tethering of peptides that mimic components of
the native ECM.17-20
Beyond cell-ECM interactions, cell-cell interactions are known to be important during
mesenchymal

condensation

and

the

regulation

of

chondrogenesis.21

Cell-cell

interactions during condensation are widely understood to be achieved via homotypic
binding of NCad, a cell-surface protein that binds the transcription factor β-catenin with
its cytosolic domain, regulating the localization of this transcription factor for proper
signaling downstream of cell-cell interaction.22-24 In fact, deletion of the extracellular or
intracellular domains, or blocking NCad interactions via antibody treatment inhibits
condensation and subsequent chondrogenesis.23,25 However, the encapsulation of cells
within hydrogels typically occurs as single cells, which then limits recapitulation of these
cell-cell interactions; thus, strategies to introduce NCad signaling into these
environments are needed. Full-length NCad has been successfully incorporated into
hydrogels, such as the surface functionalization of polyacrylamide and alginate
hydrogels,26,27 however, the sheer size of N-Cadherin (135 kDa) presents challenges
when considering incorporation throughout a 3D hydrogel.
Within the structure of NCad, a conserved three-amino acid sequence, His-Ala-Val
(HAV), exists on the adhesive interface, and synthetic peptides containing this sequence
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along with a flanking aspartic acid residue are known to exhibit NCad-like binding
activity.28-30 The incorporation of HAV into an HA hydrogel did indeed promote early
chondrogenic gene expression and subsequent matrix production of MSCs in culture
and when implanted in vivo.31 Furthermore, incorporation of this peptide into hydrogels
resulted in increased β-catenin recruitment to the membrane and subsequent
translocation to the nucleus, as is observed with NCad signaling.32
Despite these findings, the magnitude and timing of the HAV motif presentation, two
critical aspects of this essential cell-cell interaction and downstream signaling, have not
been explored. In the developing limb, NCad signaling varies greatly over space and
time, with a biphasic response to the number of NCad interactions either increasing or
reducing collagen and proteoglycan synthesis.23 In the mesenchyme, cell-surface
metalloprotease ADAM10 temporally regulates NCad interactions during development
by cleaving the extracellular domain of NCad, thereby exerting control over the β-catenin
membrane-bound and cytoplasmic pool levels.22,33,34 Mutants of N-Cadherin that lack the
extracellular domain exhibit altered localization of β-catenin and upregulation of
chondrogenic markers.35 Meanwhile, mutants of N-Cadherin whose extracellular
domains cannot be cleaved by ADAM10 prevent cartilage aggregate formation,
proteoglycan synthesis, and expression of both chondrogenic and hypertrophic markers,
likely due to the fact that cleavage of the extracellular domain of NCad results in
changes in altered β-catenin localization and, importantly, chondrogenic gene
expression.34,35 With this in mind, we functionalized HA hydrogels with peptides
containing the HAV motif at different concentrations to control the magnitude or “dose,”
and with an efficient ADAM10-cleavable domain to control the timing, to investigate how
these parameters regulate chondrogenesis and neocartilage production of MSCs in HA
hydrogels.
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5.2. METHODS
Materials were acquired from Sigma-Aldrich unless otherwise indicated.

5.2.1. MEHA SYNTHESIS
HA (75 kDa; Lifecore) was modified with methacrylates as previously described.17
Briefly, the primary hydroxyl groups of HA macromers were reacted with methacrylic
anhydride (Sigma-Aldrich) in 20-fold excess under basic conditions. The resulting
methacrylated HA (MeHA) was then dialyzed (MW cutoff 6-8 kDa) for 4 days and
lyophilized for storage. The extent of MeHA methacrylation was assessed using 1H NMR
spectroscopy and determined to be ~37% of repeat units (Figure 5.1).

Figure 5.1. 1H NMR to of methacrylated HA (MeHA). Peak analysis indicates that 37%
of of disaccharide repeats were functionalized with methacrylates.
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5.2.2. PEPTIDE DESIGN AND COUPLING TO MEHA
Stable N-cad mimetic HAV peptides (HAV, Ac-HAVDIGGGC), stable scramble peptides
(Scr, Ac-AGVGDHIGC), ADAM10-cleavable transient HAV peptides (tHAV, AcHAVDIGGGPRAEA↓LKGGGC),

transient

scramble

peptides

(tScr,

Ac-

AGVGDHIGPRAEA↓LKGGGC), and stable length-matched HAV peptides (LHAV, AcHAVDIGGGAAKREPLGGGC), where stable peptides = 827.9 g/mol and transient
peptides = 1765.0 g/mol, with a cysteine residue at the C-terminal end, were obtained
from GenScript. Purity was confirmed to be >95%, and MALDI analysis was performed
to verify peptide mass (data not shown); “↓” indicates ADAM10 cleavage site.
MeHA (100 mg) was dissolved in triethanolamine-buffered saline (TEOA buffer, pH 8)
and reacted at 37 °C overnight in the presence of either stable (9.28 mg) or transient
(19.78 mg) peptides, followed by dialysis (4 days) and lyophilization (3 days). This
coupling ratio was designed to obtain a final peptide concentration of 2 mM in a 1.5
wt% MeHA hydrogel (i.e., HA content held constant) for all functionalized macromer
stocks while consuming no more than 20% of available methacrylate groups on the
MeHA. The activity of ADAM10 on transient peptides coupled to MeHA was verified
using 0.5 mM fluorescein-modified transient HAV peptide, in PBS containing 2 nM
ADAM10.

5.2.3. HYDROGEL FABRICATION AND CHARACTERIZATION
Macromers were sterilized using a germicidal lamp for 40 minutes and subsequently
dissolved in sterile phosphate buffered saline (PBS) containing 0.05 wt% photoinitiator
2-methyl-1-[4-(hydroxyethoxy)phenyl]-2-methyl-1-propanone
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(I2959).

This

hydrogel

precursor was pipetted into a 50 µL mold, covered with a glass coverslip, and exposed
to an ultraviolet (UV) light source (Eiko, ~2.0 mW/cm2) for 10 minutes. The peptide
concentration was maintained at 2 mM in all samples (except for hydrogel controls
without any peptide coupling, denoted as MeHA) and the magnitude or dose of HAV was
controlled through the ratio of the HAV and scrambled peptides (e.g., HAV 0, HAV 50,
and HAV 100 denotes samples of 2 mM scrambled, 1 mM HAV/1 mM scrambled, and 2
mM HAV, respectively).
Acellular hydrogels (~5mm Ø, ~2 mm thickness) were tested with a Dynamic Mechanical
Analyzer (DMAQ800, TA Instruments) in unconfined compression. Hydrogels were
compressed to a maximum of 70% of their initial thickness, and the elastic compressive
modulus was determined as the slope of the stress versus strain curve at low strain (up
to 20%) using a sweep with a force ramp of 0.5 N/min to max 15 N. The mass swelling
behavior of the hydrogels was characterized by the mass ratio of swollen hydrogels
(after 24 h in PBS) to dry hydrogels.

5.2.4. CELL CULTURE AND ENCAPSULATION
Human MSCs (Lonza) were expanded to passage 3 in growth media comprised of αMEM with 16.7% (v/v) FBS (Gibco), 1% (v/v) L-glutamine (Invitrogen), and 1% (v/v)
penicillin–streptomycin (Invitrogen). Cells were harvested by rinsing with PBS and
treating with 0.05 wt% trypsin and then resuspended in 1.5 wt% macromer, 0.05 wt%
I2959, and 20 M/mL MSCs. This hydrogel precursor was slowly pipetted into 50 µL
molds, covered with glass coverslips, and exposed to a UV light source (Eiko, ~2.0
mW/cm2) for 10 minutes for crosslinking. Hydrogels were cultured in vitro in DMEM
supplemented with 1% penicillin/streptomycin, 1mM sodium pyruvate, 40 mg/ml L111

proline, 100 nM dexamethasone, 50 µg/ml ascorbic acid 2-phosphate, 1% ITS+, and 10
ng/mL TGF-β3 (chondrogenic media). For studies with small-molecule ADAM10 inhibitor
GI254023X, inhibitor was added from stock solutions to a final concentration of 5 µM in
chondrogenic media. The viability of MSCs in functionalized hydrogels was assessed
using a live/dead cytotoxicity kit (Invitrogen) according to manufacturer instructions.
Live/dead images were captured on a Leica SP5 confocal microscope.

5.2.5. GENE EXPRESSION ANALYSIS
Samples were disrupted in Trizol (Invitrogen) using a handheld tissue homogenizer;
RNA was extracted according to manufacturer specifications and measured with an ND1000 spectrophotometer (Nanodrop Technologies). 1 µg of RNA was taken from each
sample for cDNA synthesis using reverse transcriptase (Superscript II, Invitrogen) and
oligoDT as the primer (Invitrogen). Polymerase chain reaction (PCR) was then
performed using the Applied Biosystems 7300 system for Real-Time PCR with a 25 µL
reaction volume for Taqman (5′-nuclease) reactions (n=4). Primers and probes for
releant targets glyceraldehyde 3-phosphate dehydrogenase (GAPDH, housekeeping
gene), type I collagen (COL1), type II collagen (COL2), and aggrecan (ACAN) were
selected as shown in Table 5.1. Relative gene expression was assessed with
ΔΔCT method, where the fold difference is found by 2−ΔΔCt.

Table 5.1. Primer and probe sequences used for quantitative PCR.
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5.2.6. BIOCHEMICAL AND HISTOLOGICAL ANALYSIS
After MSC-laden hydrogels were cultured for 8 weeks, they were digested using papain
(1 mL/construct, 0.56 U/mL in 0.1 M sodium acetate, 10 M cysteine hydrochloric acid,
0.05 M ethylenediaminetetraacetic acid, pH 6.0) at 60°C for 16 hours. Samples were
then analyzed for sulfated glycosaminoglycan (sGAG, using dimethylmethylene blue),
DNA

(using

PicoGreen),

dimethylaminobenzaldehyde

and

and

collagen

chloramine

T

(orthohydroxyproline,
reagents)

content.21,36

using
For

the

histological analysis of constructs, all samples were fixed in 10% formalin (24 hours),
embedded in paraffin and stabilized at 4°C (24 hours), and subsequently processed
using standard histological protocols. Histological sections (5 µm) were stained using
antibodies for type I collagen (Col I, mouse monoclonal anti-collagen type 1, Sigma),
type II collagen (Col II, (mouse monoclonal anti-collagen type II, Developmental Studies
Hybridoma Bank)), and sulfated glycosaminoglycan (sGAG). For quantification, images
were first converted to 8-bit and then inverted. Mean staining intensity within randomly
placed frames for each section was measured with ImageJ (Figure 5.2).

Figure 5.2. Method for quantification of histology and immunohistochemistry.
Images were converted to 8-bit and subsequently inverted. Mean staining intensity was
then quantified for each section imaged using a randomly placed frame per section for
each group (n ≥ 9).
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5.2.7. STATISTICAL ANALYSIS
Values in this work are reported as mean values ± the standard error of the mean
(SEM). Unless otherwise specified, transformation and outlier removal were not
performed. Normalization was performed using relevant control groups (e.g. gene
expression was normalized to that of control cells plated in 2D). StatPlus:mac LE
(AnalystSoft) was used to perform statistical analyses with one-way ANOVA (and
Tukey’s honestly significant difference post hoc test of the means) to compare between
groups (n≥4), where culture duration and experimental group were independent factors.

5.3. RESULTS AND DISCUSSION
Cell-cell contact among progenitor cells in the limb bud during condensation is widely
understood to require homotypic binding of NCad, a cell-surface adhesion protein that
binds the transcription factor β-catenin with its cytosolic domain, regulating localization of
this transcription factor for proper signaling downstream of NCad binding.22-24 Cell-cell
interactions and subsequent downstream signaling via NCad are well established as
critical features of chondrogenesis and development, but nuanced control of NCad
signaling is desirable for the design of inductive materials for cartilage tissue
engineering. Prior work has established that tethered NCad mimetic HAV peptides in HA
hydrogels exhibit NCad agonistic activity due to one end being conjugated to the HA
backbone, resulting in the expected nuclear β-catenin localization in MSCs when
encapsulated within this material.31,32 Furthermore, blocking studies using antibody
treatment have confirmed that the observed enhancement of chondrogenic gene
expression in this system was indeed due to NCad interactions with these peptides.31
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Here, we drew inspiration from two key features of our understanding of development: (i)
variations in the amount of NCad interactions present in the limb bud mesenchyme12 and
(ii) the possibility of regulating NCad interactions over time by the cell-surface
metalloprotease ADAM10.22,33,34 To mimic both the magnitude and timing of NCad
signals in hydrogels, we designed photocrosslinkable macromers that allowed us to
titrate in varying amounts of tethered stable or transient NCad signal into hydrogels via
HAV peptide presentation while keeping the hydrogel properties constant.

5.3.1. CADHERIN MIMETIC PEPTIDES INFLUENCE EARLY CHONDROGENESIS IN
A DOSE-DEPENDENT MANNER
Hyaluronic acid (HA) was modified with methacrylate groups on ~37% of disaccharide
repeat units to generate a photocrosslinkable macromer that could also be modified with
peptides using a Michael addition reaction between the methacrylates and thiols (via
cysteine residues) on the peptides (Figure 5.1). Specifically, peptides containing either
the HAV motif of NCad or a non-active scrambled sequence (Figure 5.3a) were
incorporated into hydrogels at various ratios at a total concentration of 2 mM. The
incorporation of peptides at 2 mM did not significantly alter either the mass swelling
behavior (Figure 5.3b) or compressive modulus (Figure 5.3c) of hydrogels as compared
to unmodified hydrogel controls, confirming that cellular outcomes are not related to
changes in network structure or mechanical properties.

Additionally, MSCs used in

these studies were verified to express cell-surface NCad (Figure 5.4) and were
encapsulated in the HA hydrogels that were either unmodified or modified with various
peptide compositions. MSC viability was high in all hydrogel formulations for up to 14
days of culture, the time period used to assess gene expression (>90%, Figure 5.5).
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There were no macroscopic changes in construct size or opacity during this 14 day
period (Figure 5.6).

Figure 5.3. Fabrication of HA hydrogels that incorporate peptides that mimic cellcell interactions. (a) Schematic of MSC encapsulation in HA hydrogels from
macromers modified with methacrylates for crosslinking and a peptide that contains the
HAV motif to enable interaction with NCad, or a respective scrambled control (Scr). (b)
Mass swelling ratio and (c) elastic compressive modulus (E) of MeHA hydrogels without
(grey) or with (red) HAV peptide incorporated at 2 mM. (n ≥ 3 hydrogels per group, error
bars represent s.e.m.); n.s. denotes no significant differences between groups.
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Figure 5.4. Expression of NCad and ADAM10 on hMSCs. MSC cell-surface
expression of (a) NCad (anti-NCad, 1:100, Biolegend) or (b) ADAM10 (anti-ADAM10,
1:100, Biolegend) using flow cytometry.
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Figure 5.5. Viability of MSCs encapsulated in HAV hydrogels. Live/Dead viability
images at 3, 7, and 14 days, during which viability remained consistently high (>90%). (n
= 3 gels per group) Scale bar = 250 um.

Figure 5.6. Gross images of hydrogels with MSCs encapsulated. Images of
hydrogels 14 days after MSC encapsulation. Metric ruler length in mm.
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To control the HAV signal magnitude (or “dose”) in MSC-laden hydrogels, three different
ratios of HAV and scrambled peptide were incorporated onto the HA macromer for a
final hydrogel concentration of 2 mM: 100% scramble (HAV 0), 50%:50% HAV/scramble
(HAV 50), and 100% HAV (HAV100) (Figure 5.7a). After 3 days in culture, a dosedependent type II collagen gene expression response was observed, with the HAV-free
(HAV 0) condition similar to hydrogels without peptide (Figure 5.7b). The dosedependent increases in gene expression persisted for up to 7 days; however, there were
no significant differences between groups at 14 days. Aggrecan gene expression was
greatest for the highest HAV concentration at 3 days; however, these differences
diminished by 7 days and 14 days, although there were some modest improvements
over the hydrogels without peptides (Figure 5.7c). No significant changes in type I
collagen expression were observed over the course of the study (Figure 5.8). This is
consistent with our previous observations on HAV peptide modification, where early
markers of gene expression towards chondrogenesis were altered by HAV incorporation
and that these early changes resulted in long-term differences in matrix production.31
These trends also agree with what is known about cadherin regulation in development:
NCad expression increases at the onset of condensation and then diminishes with
cartilage maturation as cell-cell contacts are lost, so although the HAV peptide
presentation is stable, its effects are most prominent at the earliest timepoint
observed.23,31,37,38
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Figure 5.7. HA hydrogels functionalized with NCad mimetic peptides enhance
early chondrogenesis in a dose-dependent manner. (a) MSCs were encapsulated in
hydrogels from MeHA macromers with either HAV or Scrambled peptides incorporated,
at a magnitude or “dose” of 2 mM of peptide. The groups included either only the
Scrambled peptide (HAV 0), a 50:50 mixture of the two peptides (HAV 50), or only the
HAV peptide (HAV 100). A control without peptide (MeHA) was also investigated. Gene
expression for (b) type II collagen (COL2) and (c) aggrecan (ACAN) assessed over a 14
day culture period in chondrogenic media. (n = 4, error bars represent s.e.m.). *: P< 0.05
between groups, #: P< 0.05 compared to no peptide (MeHA) control. n.s. denotes no
significant differences between groups.
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Figure 5.8. HA hydrogels functionalized with HAV peptides do not increase
expression of dedifferentiation marker COL1. Expression of dedifferentiation marker
COL1 in MSCs encapsulated with stable HAV peptides at (a) day 3, (b) day 7, and (c)
day 14. All measurements normalized to 2D control and GAPDH. Control gel with no
peptide (MeHA) included as additional control. (n = 4 gels per group)

5.3.2. CADHERIN MIMETIC PEPTIDES INFLUENCE LONG-TERM NEOCARTILAGE
FORMATION IN A DOSE-DEPENDENT MANNER
To evaluate the effects of the HAV peptides on long-term cartilage formation, we
cultured

MSC-laden

constructs

prepared

with

different

ratios

of

macromers

functionalized with either the HAV and scramble peptides for 56 days. Quantification of
matrix components present in cartilage showed a concentration-dependent increase in
sGAG and collagen (Figure 5.9a). HAV-free (HAV 0) and no peptide control (MeHA)
groups had similar sGAG and collagen levels, whereas matrix deposition increased up to
2-fold in sGAG and 9-fold in collagen content for the 2mM HAV group after 56 days of
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culture when compared to these controls. Unconfined mechanical testing also showed
that the inclusion of HAV increased the compressive elastic modulus of the constructs
when compared to the no HAV peptide and no peptide hydrogels, which exhibited a
similar modulus (~13 kPa) (Figure 5.9b). When compared to the initial hydrogel modulus
(Figure 5.3c), there was an increase in elastic compressive modulus in all formulations
after 56 days; however, the increase (~340%) was greatest for the highest HAV
concentration when compared to MeHA gels (Figure 5.9b).

Figure 5.9. NCad interactions promote long-term neocartilage formation in a dosedependent manner. (a) Quantification of sGAG and collagen content and (b) elastic
compressive modulus of MSC-encapsulated constructs after 8 weeks of culture.
Histology and immunohistochemistry (c) quantification and (d) images of sGAG and type
I and type II collagens after 8 weeks of culture. (n = 5 hydrogels per group, error bars
represent s.e.m.). Scale bar 500 µm. *: P< 0.05 between groups, #: P< 0.05 compared
to no peptide (MeHA) control. n.s. denotes no significant differences between groups.
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Quantification of staining for sGAG and type II collagen showed a dependence on HAV
concentration (Figure 5.9c). In addition to differences between the HAV-free (HAV 0)
and low HAV (HAV 50) groups, the presence of HAV peptide (HAV 50, HAV 100)
increased the staining intensity compared to the MeHA control without peptide for both
markers, with significantly greater values for the highest HAV group. Representative
images of immunohistochemistry staining for sGAG and type II collagen revealed more
intense and uniformly distributed staining with greater doses of HAV, suggesting more
cartilage matrix elaboration in these constructs compared to scrambled and no peptide
controls (Figure 5.9d). Quantification of type I collagen sections showed low levels and
no significant differences in staining intensity between groups investigated (Figure
5.9c,d). Thus, the changes in early gene expression appear to influence matrix
production over the long term at the various HAV concentrations investigated. The
homogeneity of sGAG and collagen distribution also appears to be altered in MeHA vs.
peptide-modified hydrogels, and this may be due in part to inherent heterogeneity in the
MSC population and also to differences in ECM synthesis and deposition (e.g. ECM
crosslinking, masses and volumes of ECM secreted).
Notably, while too much cell-cell adhesion by overexpression of NCad can result in
failure to differentiate (a 2-fold increase in NCad enhances chondrogenesis, while a 4fold increase inhibits chondrogenesis)39, the doses used in this study stimulated the
greatest chondrogenesis at the highest concentration. With the peptides designed for
this study and the hydrogel used, solubility limited the investigation of higher
concentrations where perhaps inhibited chondrogenesis would be observed. Also, the
presentation of the peptide or its accessability may be inherently altered as the cells lay
down their own matrix throughout the hydrogel, in a sense to self-regulate HAV levels.
The dose dependence in the range probed here, while it does not demonstrate this
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biphasic response, agrees with this well-known magnitude-dependence of native NCadmediated cell-cell interactions in embryogenesis.22 Importantly, the mean increases in
type II collagen and sGAG synthesis in constructs with the HAV peptide being 9- and 2fold, respectively, with collagen content beginning to overtake sGAG content, is
favorable in light of the fact that the composition of native articular cartilage—where
there is more type II collagen than sGAGs--is relevant to the final tissue properties; here,
the increases in type II collagen and sGAG content led to an almost 3-fold enhancement
of hydrogel modulus.40

5.3.3. TRANSIENT PRESENTATION OF NCAD MIMETIC PEPTIDE ALTERS THE
INFLUENCE ON MSC CHONDROGENESIS
To assess how the transient presentation of the N-cad mimetic HAV motif affects early
chondrogenesis of MSCs, MeHA macromers were functionalized with HAV or scrambled
peptides containing an additional ADAM10-cleavable domain. Presentation of this
transient peptide relies on endogenous ADAM10 on MSCs to cleave the peptides and
thus reduce presentation in a time-dependent fashion (Figure 5.10a). The MSCs used
were verified to express cell-surface ADAM10 (Figure 5.4). To validate the peptide
design, acellular hydrogels functionalized with a FITC-tagged form of this cleavable
peptide were incubated in PBS in the presence or absence of exogenous ADAM10.
Peptide cleavage was measured as FITC signal in the supernatant and observed over 9
days with ADAM10 present, with minimal cleavage without exogenous ADAM10 present
(Figure 5.10b). To ensure that the larger peptides did not change the properties of the
hydrogels formed, we verified that the incorporation of these peptides did not
significantly alter their modulus (Figure 5.10c) or mass swelling ratio (Figure 5.10d).
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Again, cell viability was high in these hydrogels over a 14 day culture period (>90%,
Figure 5.11) and macroscopic differences in construct size and opacity were not
observed (Figure 5.6).

Figure 5.10. Fabrication of hydrogels with transient presentation of NCad mimetic
peptides by metalloprotease ADAM10. (a) Schematic of MSCs within hydrogels
containing transient peptides regulated by ADAM10, and transient NCad mimetic HAV
peptide and control scrambled peptide sequences. (b) Release of FITC-labeled transient
peptide coupled to the MeHA macromer from bulk hydrogels by ADAM10 and compared
to control buffer without ADAM10. (c) Elastic modulus (E) and (d) mass swelling ratio of
MeHA hydrogels without (grey) or with (orange) transient HAV peptide incorporated at 2
mM. (n ≥ 3 hydrogels per group, error bars represent s.e.m.); n.s. denotes no significant
differences between groups.
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Figure 5.11. Viability of MSCs after encapsulation in tHAV hydrogels. Live/Dead
viability images at 3, 7, and 14 days, during which viability remained consistently high
(>90%). (n = 3 gels per group) Scale bar = 250 um.

To control the signal magnitude of transient HAV (tHAV), three different ratios of tHAV
and transient scrambled peptide were incorporated into MeHA macromers: 100%
transient scramble (tHAV 0), 50%:50% transient HAV/transient scramble (tHAV 50), and
100% transient HAV (tHAV 100) (Figure 5.12a). In contrast to our observations in the
stable (non-transient) groups, after 3 days in culture there were no significant differences
in expression of chondrogenic gene markers type II collagen (Figure 5.12b) and
aggrecan (Figure 5.12d). There was a significant increase in the expression of type II
collagen and aggrecan in all peptide-containing groups by 7 days, and subsequently no
temporal differences in expression between 7 and 14 days. As observed with the stable
HAV peptides, however, no significant changes in type I collagen expression were
observed in these groups for the duration of the study (Figure 5.13). These observations
are consistent with the understanding that, in development, premature or induced
shedding of N-Cadherin-mediated interactions results in impaired chondrogenesis.37,38
To verify that the length of the peptide sequence did not influence these findings, MeHA
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was functionalized with a peptide of the same length as the transient peptide that
contained the HAV motif but now incorporating a scrambled cleavage domain (Lengthmatched HAV that is not ADAM10-cleavable, or LHAV) (Figure 5.14). When MSCs were
encapsulated in this hydrogel, we observed increases in early type II collagen and
aggrecan gene expression, and subsequent sGAG and collagen deposition, similar to
the earlier stable HAV studies (Figure 5.14, 5.15). Thus, it appears that the ADAM10
cleavage of the designed peptide occurs rapidly and fails to influence chondrogenesis in
the hydrogels, confirming that the duration of peptide presentation is important.

Figure 5.12. Transient NCad mimetic peptides do not enhance early
chondrogenesis. (a) MSCs were encapsulated in hydrogels from MeHA macromers
with either transient tHAV or Scrambled peptides incorporated, at a dose of 2 mM of
peptide. The groups included either entirely the Scrambled peptide (tHAV 0), a 50:50
mixture of the two peptides (tHAV 50), or entirely the transient HAV peptide (tHAV 100).
A control without peptide (MeHA) was also investigated. Gene expression for (b) type II
collagen (COL2) and (c) aggrecan (ACAN) assessed over a 14 day culture period in
chondrogenic media. (n = 4, error bars represent s.e.m.). *: P< 0.05 between groups, #:
P< 0.05 compared to no peptide (MeHA) control. n.s. denotes no significant differences
between groups.
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Figure 5.13. HA hydrogels functionalized with tHAV peptides do not increase
expression of dedifferentiation marker COL1. Expression of dedifferentiation marker
COL1 in MSCs encapsulated with transient HAV (tHAV) peptide at (a) day 3, (b) day 7,
and (c) day 14. All measurements normalized to 2D control and GAPDH. Control gel
with no peptide (MeHA) included as additional control. (n = 4 gels per group)
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Figure 5.14. HA hydrogels with length-matched HAV (LHAV) peptides enhance
early chondrogenesis. (a) Comparison of peptide sequences, demonstrating equal
peptide length but lack of cleavable domain (indicated by ↓) in LHAV peptides.
Expression of (b) COL2 and (c) ACAN in hydrogels containing tHAV peptides vs. LHAV
peptides, with no peptide (MeHA) condition as control. (n = 4 hydrogels per group, error
bars represent s.e.m.). *: P< 0.05 between groups, #: P< 0.05 compared to no peptide () control, n.s. denotes no significance between groups.
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Figure 5.15. LHAV interactions promote long-term neocartilage formation.
Quantification of (a) biochemical (GAG, collagen) content and (b) histology and
immunohistochemistry of tHAV 100 hydrogel vs. a scramble control peptide with intact
HAV motif but scrambled ADAM10-cleavable sequence (LHAV100). (n = 5 hydrogels per
group, error bars represent s.e.m.). #: P< 0.05 compared to no peptide (MeHA) control,
n.s. denotes no significance between groups.

To further explore the role that HAV timing plays on MSC chondrogenesis, constructs
were treated with the small-molecule ADAM10 inhibitor GI254023X to further stabilize
the presentation of HAV to encapsulated MSCs, as well as cell-surface NCad (Figure
5.16a). Gene expression at an early culture time of 3 days was used, since changes in
chondrogenesis were clearly different with the presence of the stable HAV peptide in this
time frame. With respect to type II collagen expression (Figure 5.16b), the addition of
the ADAM10 inhibitor did not alter expression in hydrogels without peptide (MeHA) or
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those with the incorporation of 2mM of the stable HAV peptide (HAV 100); however,
there was elevated expression of type II collagen in the transient HAV group (tHAV 100),
indicating that expression is rescued when peptide cleavage is blocked. With respect to
aggrecan expression (Figure 5.16c), the addition of the ADAM10 inhibitor resulted in
decreased aggrecan expression in hydrogels without peptide (MeHA) or those with the
incorporation of 2mM of the stable HAV peptide (HAV 100), likely due to some specific
alteration in the transcriptional program for aggrecan production in the presence of the
inhibitor. However, this decrease in aggrecan expression was rescued in the transient
HAV

group,

as

the

decreased

expression

was

counteracted

by

enhanced

chondrogenesis when peptide cleavage is blocked (and thus HAV presentation is
maintained).

In other words, inhibiting ADAM10-mediated cleavage of peptide did

enhance chondrogenesis in the form of both type II collagen and aggrecan expression.
Interestingly, there was no statistical difference in the expression of either aggrecan or
type II collagen between the stable and transient HAV groups in the presence of the
inhibitor. Taken together, these results indicate that cellular control of HAV presentation,
here via the protease activity of ADAM10, can mediate MSC chondrogenesis.
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Figure 5.16. Inhibition of ADAM10 recovers early chondrogenic gene expression in
cell-laden hydrogels with cleavable peptides. (a) Schematic of MSCs within
hydrogels containing transient peptides regulated by ADAM10 and in the presence of
ADAM10 inhibitor GI254023X. Gene expression of (b) type II collagen (COL2) and (c)
aggrecan (ACAN) after 3 days of culture in chondrogenic media for control hydrogels
without peptides (MeHA) or 2mM of either transient HAV (tHAV 100) or stable HAV
peptides (HAV 100), alone (solid bars) or with inhibitor (dashed bars). (n = 4 hydrogels
per group) #: P< 0.05 compared to respective untreated control; other comparisons were
consistent with prior studies. n.s. denotes no significant differences between groups.
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5.3.4. TRANSIENT TIMING OF NCAD MIMETIC PEPTIDE PRESENTATION ALTERS
ITS INFLUENCE ON LONG-TERM NEOCARTILAGE FORMATION
To evaluate the effects of transient NCad-mimetic HAV (tHAV) peptides on long-term
cartilage formation, MSC-laden constructs were prepared with different ratios of
macromers functionalized with either tHAV or transient scramble peptides and cultured
for 56 days. No peptide control (MeHA) groups had similar sGAG content to all transient
peptide groups, and similar Col II content to transient HAV-containing groups (Figure
5.17a). Thus, they did not show the concentration-dependent increase in cartilage matrix
that was observed with hydrogels functionalized with stable HAV peptides. Unconfined
mechanical testing also did not show any concentration-dependent increase in modulus
(~16 kPa), with the no peptide control group exhibiting a slightly lower modulus than the
transient peptide-containing groups (~12 kPa) (Figure 5.17b). Quantification and images
of staining for sGAG and type II collagen showed that the HAV-concentration
dependence observed with stable HAV peptides was mitigated, while again type I
collagen exhibited no transient HAV-concentration dependence (Figure 5.17c,d). In
agreement with our observations of early gene expression, MSC-laden hydrogels
functionalized with the control LHAV mimetic peptide showed significant increases in
sGAG and collagen content after long-term culture, as measured by biochemical assays,
histology, and immunohistochemistry (Figure 5.15). Thus, this work suggests that the
timing of the HAV peptide is indeed important to its effect on encapsulated MSCs, as
rapid cleavage limits the influence on cell behavior.
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Figure 5.17. Transient NCad interactions do not enhance long-term neocartilage
formation. (a) Quantification of sGAG and collagen content and (b) elastic modulus of
constructs after 8 weeks of culture. Histology and immunohistochemistry (c)
quantification and (d) images of sGAG and type I and type II collagen after 8 weeks of
culture. (n = 5 hydrogels per group, error bars represent s.e.m.). Scale bar 500 µm. *: P<
0.05 between groups, #: P< 0.05 compared to no peptide (MeHA) control. n.s. denotes
no significant differences between groups.

The findings of this study indicate that the inclusion of an HAV peptide into hydrogels
enhances chondrogenesis in a magnitude dependent manner, as long as the peptide
presentation is sustained to influence MSC behavior. Enhanced sGAG, collagen, and
mechanics were observed, although the values did not reach those of native cartilage
tissue.41 Although the ADAM10 regulated presentation of the HAV peptide here did not
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enhance chondrogenesis, it does emphasize the importance of timing to enhance MSC
response. Potentially, self regulation in such systems—through the deposition of matrix
that occurs in 3D as chondrogenesis and cartilage formation proceed—is sufficient, and
this mimics the transition from cell-cell to cell-ECM interactions during development,
which can be different than how mechanical signaling occurs in 2D HA cultures of
MSCs.42 One important consideration in these studies is that HAV peptide was shown as
chondroinductive in the presence of TGF-β3; whether the peptide is chondroinductive
alone, particularly in vivo, remains a consideration for future investigation. Additionally,
further enhancing NCad signaling in hydrogels via variations in peptide design and
presentation could be considered. For instance, NCad dimerization on the cell surface is
important for proper signal transduction, and, accordingly, cyclic tandem repeatcontaining peptides have been reported to exert greater agonist activity,43 which was not
included in the current study. The spatial clustering of mimetic peptides in the hydrogel
microenvironment to encourage adherens junction formation and stability may also need
to be optimized to enhance peptide-cell interaction on cell signaling, as this stable
cluster formation is important in cadherin signaling in general.44

5.4. CONCLUSIONS
The findings in this study demonstrate that tethered NCad mimetic peptides that mimic
cell-cell interaction via NCad binding both enhance the early expression of chondrogenic
markers and promote long-term cartilage matrix production in a strong magnitudedependent fashion. Furthermore, these results suggest that the timing and duration of
presentation is critical: highly transient peptides with the same NCad mimetic moiety did
not exert the same effects on MSC chondrogenesis and matrix production, whereas the
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blocking of this cleavage with protease inhibition enhanced outcomes. These findings
underscore the potential of nuanced material design to guide differentiation by providing
biochemical signals that capture the complex cell microenvironment found during tissue
development.
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CHAPTER 6
UNDERSTANDING THE TEMPORAL EVOLUTION OF PERICELLULAR MATRIX AT
THE CELL-HYDROGEL INTERFACE

6.1. INTRODUCTION
In tissues throughout the body, the pericellular and extracellular matrices guide cell
behavior. In both developing and mature cartilage tissue, matrix synthesis and
turnover occur continuously, and these processes are in fact essential for tissue
homeostasis.1 This balance can be disturbed by injury-induced damage and
subsequent degradation of the cartilage matrix, which due to limited self-repair
processes in cartilage has necessitated the development of clinical interventions.2,3
Cartilage tissue engineering seeks to meet this ongoing clinical need, and the design
of hydrogels that encapsulate relevant cell types has become a well-characterized
approach to repair cartilage tissue.3
Within this context, cells must not only synthesize large quantities of matrix, but also
retain, assemble, and remodel this matrix within the pericellular space. How an
engineered construct matures depends on the cells’ abilities to perform these
functions, particularly as individual cells deposit matrix that eventually interacts and
integrates to achieve functional tissue properties.4,5 Just as the matrix influences cell
behavior in native tissues in vivo, the structure and composition of the matrix
surrounding cells in these in vitro constructs can also regulate the extent of
chondrogenesis and thus the maturation of the construct.6 Along those lines, the initial
engineered hydrogel biochemical and biophysical properties play an important role in
construct maturation, as it has been noted that the hydrogel crosslink density can
140

have a profound effect on matrix formation and distribution, either permitting or
restricting the distribution of deposited matrix.7,8

Matrix formation in these hydrogels is commonly reported using bulk biochemical
measures collected over time, but such population-level measurements of matrix
synthesis do not provide spatial information regarding the deposition and organization
of matrix by individual cells at their surfaces. They also do not reveal how this matrix
deposition affects the cell-hydrogel interface that often contains engineered cues to
influence cell behavior (e.g., hyaluronic acid, HAV peptide to mimic N-cadherin).9,10
Methods such as autoradiography with radiolabeled sulfate and proline can provide
insight into the localization of proteoglycans and collagens around individual cells,
and this has demonstrated temporal changes in the rate and spatial distribution of
secreted matrix.11-13 However, this approach involves the use of radioisotopes that
require additional measures for handling, and moreover, the punctate appearance of
autoradiographic signals offers limited resolution in probing the structure and
organization of this cell-secreted (nascent) matrix.
A metabolic labeling approach that relies on residue-specific incorporation of
noncanonical amino acids into protein synthesis enables high fidelity fluorescent
visualization of nascent pericellular matrix (PCM) protein deposition and remodeling.14
This can easily be achieved during in vitro culture by limiting the canonical amino acid
from the media and replacing it with its non-canonical analog.14,15 The endogenous
translation machinery then incorporates the analog into proteins during synthesis.
Among the diverse non-canonical amino acids that have been identified, there are
some that contain bio-orthogonal functional groups that, following incorporation into
newly synthesized protein, can then be labeled with highly selective fluorescent tags
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via strain-promoted [3+2]azide-alkyne cycloaddition to allow visualization of nascent
proteins with microscopy.15
In contrast to site-specific methods that require genetic manipulation or engineered
biosynthetic machinery that only substitutes residues at targeted locations, this
method results in global incorporation of this analog across the nascent proteome.14
This labeling capability was previously used to investigate protein synthesis and
intracellular protein trafficking in cell monolayers,15-18 bacteria,19,20 larval zebrafish,21
and drosophila.22 Among these recent works, the azide-bearing non-canonical
methionine analog azidohomoalanine (AHA) in particular exhibited no toxicity to either
live mammalian cells

or whole mammalian organisms at the low concentrations

required for labeling of methionine-containing proteins.16,17 Similarly, metabolic
labeling of glycans has been demonstrated in numerous contexts using the synthetic
analogs

of

sugars,

such

as

in

the

case

of

the

mannose

analog

N-

azidoacetylatedmannosamine-tetraacylated (ManNAz).23-26 Both of these methods
may utilize copper-free click chemistry for fluorescent staining that is compatible with
live cells, which is important to maintain the labeling of matrix to the extracellular
space.

In the context of hydrogels for cartilage tissue engineering, many cell types are able to
rapidly synthesize and assemble PCM within these hydrogel microenvironments,27,28 and
it is important to understand how this affects the timing of presentation of biochemical
moieties that are engineered into these hydrogels to modulate cell behavior.29 In fact, the
deposition and elaboration of nascent PCM proteins has been described in a tissue
engineering context (albeit via staining fixed cells),30 as well as to understand the
influence of PCM deposition and remodeling by cells to regulate their own
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mechanosensing capabilities and fate.31 However, the effect of this PCM protein
deposition on the cell-hydrogel interface is still not well understood. In addition to
proteins, the glycan component of the nascent PCM is of particular importance in
tissue engineering because the distributed glycan network contributes 50-75% of the
equilibrium modulus of cartilage.32 Again, the formation and distribution of these
glycans, as well as their own potential effects at the cell-gel interface, have been
minimally explored.

To investigate both proteins and sugars at the cell-hydrogel interface, we make use of
primary bovine chondrocytes (bCHs) as a model cell type that secretes a robust and
relatively homogenous PCM and is therefore optimal to address the questions at hand.30
We utilize imaging techniques enabled by live-cell labeling using the non-canonical
amino acid AHA and non-canonical sugar ManNAz to visualize PCM elaboration by cells
within hydrogels with the intent to better understand: (i) how the hydrogel design
influences PCM evolution, and (ii) the spatiotemporal displacement of the hydrogel from
the cell membrane by the PCM. Further, hydrogels can be visualized using embedded
nanometer-scale fluorescent beads in combination with this labeling chemistry, and thus
the temporal changes in chondrocyte interactions with their microenvironments in HA
hydrogels can be assessed at the single-cell level.
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6.2. METHODS
6.2.1. MATERIAL SYNTHESIS
Norbornene-modified HA (NorHA) was synthesized by first converting sodium
hyaluronate (75 kDa, Lifecore, Chaska, MN) to HA tert-butyl ammonium salt (HA-TBA)
using Dowex 50W proton exchange resin. HA-TBA was then reacted in the presence of
(3 equivalent), 4-(dimethylamino)pyridine (1.5 equivalent) and ditert-butyl dicarbonate
(Boc2O, 0.4 equivalent). The product was purified by dialyzing against deionized water
for ~2 weeks, adding sodium chloride (NaCl) (1 g NaCl per 100 mL of solution), and then
precipitating with 10-fold excess acetone at 4°C. The precipitate was re-dissolved in
deionized water, frozen at -80°C, and then lyophilized. The macromer was characterized
by 1H nuclear magnetic resonance (NMR) (Bruker Advance 360 MHz, Bruker, Billerica,
MA; Figure 6.1) and then stored at -20°C.

Figure 6.1. 1H NMR of norbornene-modified hyaluronic acid (NorHA). Peak analysis
indicates ~25% modification of disaccharide repeats with norbornene pendant groups.

144

6.2.2. HYDROGEL FABRICATION
Macromers were sterilized using a germicidal lamp in a laminar flow hood for 30 min.
NorHA was dissolved in sterile phosphate buffered saline (PBS) containing 0.05 wt% 2methyl-1-[4-(hydroxyethoxy)phenyl]-2-methyl-1-propanone (Irgacure 2959, I2959, Ciba,
Basel, Switzerland) and DL-dithiothreitol (DTT, Millipore Sigma) for crosslinking. The
degree of crosslinking was controlled via the ratio of thiols in DTT to norbornene groups
(XDTT).

6.2.3. MECHANICAL ANALYSIS
Hydrogels (5 mm diameter cylinders) underwent compression testing using a Dynamic
Mechanical Analyzer Q800 (DMAQ800, TA Instruments, New Castle, DE). Samples
were preloaded (0.01 N) and compressed via force ramp (0.5 N min−1) until they reached
70% of their initial thickness. The compressive moduli were calculated as the slope from
10% to 20% strain.

6.2.4. CELL ENCAPSULATION
Primary bovine chondrocytes (bCHs) were isolated from juvenile bovine knees
(Research 87, Boylston MA) and encapsulated at a density of 5 x 106 cells/mL in NorHA
hydrogel films (~660 µm thickness) that were cut into 5 mm x 5 mm constructs and
cultured in 48-well plates. When stated, red-fluorescent polystyrene beads (nominal
diameter ~ 0.190 - 0.210µm, emission 600-650 nm, Bangs Laboratories) were coencapsulated with cells at ~3 x 1010 beads/mL to visualize the hydrogels. Constructs
were cultured in ‘AHA media,’ a chondrogenic media consisting of glutamine-,
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methionine- and cystine-free high-glucose DMEM, 0.1 µM dexamethasone (Sigma
Aldrich), 4 mM GlutaMAXTM supplement (Thermo Fisher), 0.201 mM L-cystine (Sigma
Aldrich), 100 µg/mL sodium pyruvate (Cellgro), 1.25 mg/mL bovine serum albumin
(BSA), 0.1% ITS+ premix, 50 µg/mL ascorbate 2-phosphate, 40 µg/mL L-proline, and
1% penicillin-streptomycin-amphotericin, further supplemented with 10 ng/mL TGF-β3
and 0.1 mM L-azidohomoalanine (AHA), or ‘ManNAz media’ consisting of glutamine-,
methionine- and cystine-free high-glucose DMEM), 0.1µM dexamethasone, 4 mM Lglutamine, 0.201 mM L-cystine 100 µg/mL sodium pyruvate, 1.25 mg/mL BSA, 0.1%
ITS+ Premix, 50 µg/mL ascorbate 2-phosphate, 40 µg/mL L-proline, and 1% penicillinstreptomycin-amphotericin, further supplemented with 10 ng/mL TGFβ-3, and 0.05 mM
N-azidoacetylmannosamine tetraacylated (ManNAz). Constructs were incubated for up
to 7 days in the designated media for either protein or glycan live-cell labeling.

6.2.5. CELL VIABILITY
For viability analysis, bCHs encapsulated in hydrogels were stained using a Live/Dead®
cell viability assay (Invitrogen) according to the manufacturer’s instructions. Viability was
quantified from confocal stacks acquired using a Leica SP5 II confocal microscope and
reported as the ratio of calcein-AM-stained cells to the total cell number.

6.2.6. NASCENT MATRIX STAINING
Constructs were harvested by first staining live cells using a fluorophore-conjugated
cyclooctyne (DBCO-488) in PBS containing 1% BSA. Hydrogels were washed twice in
PBS, followed by a 40 min incubation in 30 µM DBCO-488 at 37°C /5% CO2. After three
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washes with PBS, hydrogels were fixed in 10% formalin for 30 min at room temperature
followed by three washes in PBS and storage at 4°C. These fixed constructs were then
stained with a plasma membrane stain (CellMask Deep Red, 1:1000 dilution, Invitrogen)
and a nuclear stain (Hoechst 33342, 5 µg/mL, Thermo Fisher) for 40 minutes and
subsequently washed twice with PBS immediately prior to imaging.

6.2.7. IMAGING AND QUANTIFICATION
Constructs were imaged using a Leica SP5 II confocal microscope to acquire z-stacks of
nuclei, cell membrane, beads, and labeled PCM. Bead encapsulation was validated by
selecting random 50 µm x 50 µm squares at least 20 µm removed from the cells and
PCM signals (n≥3 squares) in images acquired at 190x1.4 NA (0.15 µm per pixel) and
quantifying mean bead densities at each timepoint. Average local PCM thickness at the
midsection of each cell was measured radially (n=5 measurements per cell) as the
distance that the PCM extends past the outer edge of the cell membrane. The bead-tomembrane distance was quantified as the distance between the outer edge of the cell
membrane to the closest proximal bead at the cell midsection. Radial intensity profiles
were generated by collecting and averaging intensity profiles (n=5 per cell) across the
midsections of n≥20 cells per group, where each profile was normalized to its max
intensity and truncated to only include the signal starting at the outer edge of the cell
membrane (Figure 6.2)
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Figure 6.2. Radial profile analysis of nascent PCM deposition. The membrane and
PCM signal is parsed from the mid-plane of each cell, and the intensity of this signal is
quantified using radial profile analysis (n=5 profiles per cell). Representative radial
profiles use dotted lines to indicate the mean intensity and shaded regions to indicate
the 95% confidence interval.

6.3. RESULTS AND DISCUSSION

6.3.1. DEPOSITION OF NASCENT MATRIX PROTEINS OCCURS EARLY IN 3D
HYDROGELS
To visualize early nascent matrix deposition, we adapted a labelling technique where
methionine analogs containing reactive azide groups (L-azidohomoalanine, AHA) are
incorporated into proteins as they are synthesized by cells and then labelled via a bioorthogonal strain-promoted cyclo-addition with a fluorophore-conjugated cyclooctyne
(DBCO-488) (Figure 6.3a). To demonstrate spatiotemporal nascent matrix deposition,
we encapsulated bovine chondrocytes (bCHs) in 4wt% 5 kPa norbornene-modified HA
(NorHA) hydrogel films covalently crosslinked via a thiol-ene reaction. The viability of
encapsulated cells remained high at ~93% for up to 7 days of culture in AHA media
(Figure 6.3b). DBCO-488 labeling in analog-supplemented chondrogenic media
revealed nascent protein deposition in the pericellular space, which was heterogenous
across cells (Figure 6.3c).
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Figure 6.3. Metabolic labeling of nascent PCM proteins. (a) Chondrocytes are
encapsulated in a NorHA hydrogel and cultured in chondrogenic media containing the
synthetic methionine analog AHA. This analog is incorporated during nascent protein
synthesis and can be subsequently stained using strain-promoted click chemistry with a
DBCO dye. (b) Cell viability at day 7 (n=3, mean ± s.e.m.) and (c) imaging of cell
distribution and a cortical ring of nascent proteins accumulated during 7 days of culture.

Nascent proteins were visualized as early as 1 day after encapsulation and culture in
chondrogenic media, with increased thickness of the matrix (monitored as the distance
between the cell membrane and the edge of these proteins) over the culture for up to 7
days with some fibrillar structures protruding into the hydrogel (Figure 6.4a,b). This layer
increased over time and by day 7, cells had assembled a protein layer with a thickness
of ~4 µm (Figure 6.4c).
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Figure 6.4. Cells rapidly deposit nascent proteins at the cell surface. (a) Images of
nascent proteins surrounding chondrocytes after encapsulation in hydrogels and culture
for up to 1 week. Scale bar 10 um (left), 5 um (right). (b) Radial profile analysis of
proteins and cell membranes (arrows indicate the end of the protein layer), and (c)
quantification of the thickness of this protein layer over time. n=20 cells, mean and 95%
confidence interval shown in (b); mean ± SD in (c), **p≤ 0.01, ****p ≤ 0.001.

6.3.2. DEPOSITION OF NASCENT MATRIX GLYCANS OCCURS EARLY IN 3D
HYDROGELS
In addition to adapting a method for protein labeling, we also sought to visualize glycan
deposition in hydrogels using a synthetic mannose analog containing reactive azide
groups (N-azidoacetylmannosamine tetraacylated, ManNAz) that can be incorporated
into glycans as they are synthesized. These can then be stained via the same bioorthogonal strain-promoted cyclo-addition with a fluorophore-conjugated cyclooctyne
(DBCO-488; Figure 6.5a). We encapsulated bCHs in 4wt% 5 kPa NorHA hydrogel films
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that were then incubated in analog-supplemented chondrogenic media. Cell viability
remained high for up to 7 days of culture at ~90% (Figure 6.5b), and DBCO-488 labeling
revealed a glycan ring around cells in addition to heterogeneity across cell populations
(Figure 6.5c).

Figure 6.5. Metabolic labeling of nascent glycan synthesis. (a) Chondrocytes are
encapsulated in a NorHA hydrogel and cultured in chondrogenic media containing the
synthetic mannose analog ManNAz. This analog is incorporated during nascent glycan
synthesis and can be be stained using strain-promoted click chemistry with a DBCO dye.
(b) Cell viability at day 7 (n=3, mean ± s.e.m.) and (c) imaging of cell distribution and a
cortical ring of nascent glycans accumulated during 7 days of culture.

Much like nascent proteins, nascent glycans were visualized as early as 1 day after
encapsulation and culture in chondrogenic media (Figure 6.6a). This rapidly increased
thickness up to 3 days, and the layer of glycans that developed was nearly 9 µm thick
after 7 days (Figure 6.6b,c). This was approximately twice the thickness of the
measured protein layer.
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Figure 6.6. Cells rapidly deposit nascent glycans at the cell surface. (a) Images of
nascent glycans (cyan) surrounding chondrocytes after encapsulation in hydrogels and
culture for up to 1 week. (b) Radial profile analysis of glycans and cell membranes, and
(c) quantification of the thickness of this glycan layer over time. Scale bar 10 um (left), 5
um (right). n = 20 cells, mean and 95% confidence interval shown in (b); mean ± SD in
(c), ****p ≤ 0.001.

6.3.3. PCM DISTRIBUTION IS INFLUENCED BY HYDROGEL PROPERTIES
Next, based on prior work, we probed whether the properties of the hydrogel
environment influence the distribution of this nascent PCM. Specifically, we probed the
effects of crosslink density and macromer concentration, as these parameters alter the
hydrogel’s structural properties and may thus either facilitate or impede the distribution
of matrix components. We quantified the spatiotemporal protein and glycan profiles for
bCHs encapsulated in 4 wt% NorHA (modulus ~ 5 kPa) and 2 wt% NorHA (modulus ~20
kPa) hydrogels (to compare changes in crosslink density) and compared them to those
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in the 4 wt% NorHA (~5 kPa) hydrogel (to compare changes in macromer concentration
(Figure 6.7a). The modulus was varied by altering the level of crosslinker in the
formulations. The mean viability across the hydrogel formulations studied was ≥90% for
up to 7 days in both AHA and ManNAz media (Figure 6.7b).

Figure 6.7. Validation of hydrogel properties and cell viability. (a) Elastic moduli of
all hydrogel formulations studied, and (b) cell viability data at Day 7 after bCH
encapsulation in various hydrogel formulations and incubation in either AHA and
ManNAz media.

Increased crosslinking density in 4 wt% 20 kPa gels resulted in decreased cortical
protein thickness (Figure 6.8). Similar trends were observed in glycans (Figure 6.9).
These differences were greatest at the latest timepoint studied: at day 7, the mean PCM
thickness was ~1.8 fold (4.5 µm versus 2.5 µm) for proteins and ~1.5 fold (4 µm versus 6
µm) for glycans (Figure 6.8, Figure 6.9). On the other hand, there were no differences
in nascent protein elaboration in the 2 wt% 5 kPa versus the 4 wt% 5 kPa constructs,
engineered to have similar crosslink density (as measured through mechanics) but
different concentrations of the macromer, which suggests that macromer concentration
does not play a role in this regime (Figure 6.10). This was measured only with proteins
to date, given that they were expected to show the greatest differences.
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Figure 6.8. Crosslink density alters nascent protein deposition. (a) Images of AHAlabeled cells in 4 wt% 5 kPa (left, low crosslink density) and 4 wt% 20 kPa (right, high
crosslink density) hydrogels at Day 7. (b) Representative cell showing nascent protein
staining in hydrogels with low (5 kPa) or high (20 kPa) crosslink density. (c)
Quantification of cortical protein thickness. Scale bar 10 um (left), 5 um (right). n = 20
cells, mean ± SD, ***p≤ 0.001.
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Figure 6.9. Crosslink density alters nascent glycan deposition. (a) Images of
ManNAz-labeled cells in 4 wt% 5 kPa (left, low crosslink density) and 4 wt% 20 kPa
(right, high crosslink density) hydrogels at Day 7. (b) Representative cell showing
nascent glycan staining in hydrogels with low (5 kPa) or high (20 kPa) crosslink density.
(c) Quantification of glycan ring thickness. Scale bar 10 um (left), 5 um (right). n = 20
cells, mean ± SD, ***p≤ 0.001.

155

Figure 6.10. Macromer concentration does not alter nascent protein deposition. (a)
Nascent protein staining in hydrogels with low (2 wt%) or high (4 wt%) macromer
density. (b) Quantification of cortical protein thickness. Scale bar 10 um (left), 5 um
(right). n = 20 cells, mean ± SD.

6.3.4. NASCENT PCM PHYSICALLY DISPLACES THE HYDROGEL OVER TIME
To investigate the relationship between matrix elaboration and the physical location of
the hydrogel at the cell-hydrogel interface, we co-encapsulated bCHs with fluorescent
beads of appropriate size (~0.2 µm). Because the size of the beads is much bigger than
the average mesh size in the hydrogel formulations studied, beads are immobilized in
the network upon gelation, but they did not perturb crosslinking due to a lack of reactive
groups on their surface. To probe the stability and distribution of these beads, we
encapsulated beads in 4wt% 5 kPa gels and quantified bead stability as the bead
concentration in confocal images of hydrogel films over time at 0, 1, 3, and 7 days.
Beads were well-distributed, and their number remained highly consistent at ~127-132
beads/50 µm x 50 µm ROI over the duration of the study (Figure 6.11a,b), confirming
that beads are immobile and do not aggregate or degrade over time in the hydrogel.

156

Figure 6.11. Fluorescent bead immobilization in hydrogels. (a) Confocal
visualization of beads embedded in NorHA hydrogels for up to 7 days of incubation. (b)
Quantification of beads per ROI (50 x 50 µm) over time. Mean ± SD.

These constructs were stained, fixed, and imaged using confocal microscopy at day 0, 1,
3, and 7 days to evaluate PCM deposition and bead displacement (Figures 6.12, 6.13).
The patterns in the mean thicknesses of nascent proteins and glycans in these
constructs were consistent with those in constructs without beads. By day 3, there were
relatively modest differences in the minimum bead distance from the cell surface, and by
day 7 this distance had markedly increased to a mean of >1 µm (Figures 6.12c, 6.13c).
This pattern of bead displacement was consistent across timepoints and labeling
conditions, and at day 7, the bead distances in AHA-labeled constructs were comparable
to those in the ManNAz-labeled ones. Notably, the spatiotemporal profile of bead
displacement from the cell surface seemed to correlate with protein deposition more so
than that of the glycan component. For example, beads consistently co-localized with
the extensive glycan ring, whereas they were nearly always excluded from the dense
protein layer. In all cases, beads seldom, if ever, localized in the cytoplasm of cells.
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Figure 6.12. Nascent protein deposition physically displaces the hydrogel over
time. (a) Nascent protein staining in hydrogels visualized with encapsulated fluorescent
beads (right image without nascent proteins shown to facilitate easier visualization of the
beads). (b) Method for calculating perpendicular bead distance from the cell membrane.
(c) Quantification of the distance between the cell membrane and the closest bead.
Scale bar 10 um (left), 5 um (middle, right). n = 20 cells, mean ± SD, *p≤ 0.05, ****p ≤
0.001.
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Figure 6.13. Deposited nascent glycan can co-localize with the hydrogel. (a)
Nascent glycan staining in hydrogels visualized with encapsulated fluorescent beads
(right image without nascent glycans shown to facilitate easier visualization of the
beads). (b) Method for calculating perpendicular bead distance from the cell membrane.
(c) Quantification of the distance between the cell membrane and the closest bead.
Scale bar 10 um (left), 5 um (middle, right). n = 20 cells, mean ± SD, *p≤ 0.05, ****p ≤
0.001.

6.3.5. HYDROGEL DISPLACEMENT IS INDEPENDENT OF GEL PROPERTIES
Finally, in order to build upon the observations we made above, we sought to probe the
relationship between the properties of the hydrogel itself and this displacement of the
hydrogel from the cell-hydrogel interface. We varied the same parameters (i.e., crosslink
density, macromer concentratioin) as shown above (Figure 6.7). Comparisons of the
spatiotemporal profiles of both bead displacement and nascent PCM formation in 4 wt%
5 kPa, 2 wt% 5 kPa, and 4 wt% 20 kPa NorHA hydrogels revealed that in spite of the
differences in matrix elaboration, the displacement of the hydrogel from the cell surface
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was consistent under all conditions tested (Figures 6.14, 6.15). For instance, in AHAlabeled constructs, the mean displacement at 7 days was ~1 µm for 4 wt% 5 kPa, ~1 µm
for 4 wt% 20 kPa, and ~1 µm for 2 wt% 5 kPa hydrogels, which suggests that the
evolution of this cell-hydrogel interface is a robust phenomenon that occurs independent
of macromer concentration and crosslinking density in 3D hydrogels.

Figure 6.14. Crosslink density does not alter gel displacement from the cellhydrogel interface. (a) Measurement of bead positions in hydrogels with low (5 kPa) or
high (20 kPa) crosslink density. (b) Nascent protein staining in hydrogels containing
beads (right image without nascent proteins shown to facilitate easier visualization of the
beads). Quantification of (c) closest bead distance from the cell membrane and (d)
cortical protein thickness. Scale bar 10 um (left), 5 um (middle, right). n = 20 cells, mean
± SD, ***p≤ 0.001.
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Figure 6.15. Macromer concentration does not alter gel displacement from the
cell-hydrogel interface. (a) Measurement of bead positions in hydrogels with high (4
wt%) or low (2 wt%) macromer concentrations. (b) Nascent protein staining in hydrogels
containing beads (right image without nascent proteins shown to facilitate easier
visualization of the beads). Quantification of (c) closest bead distance from the cell
membrane and (d) cortical protein thickness. Scale bar 10 um (left), 5 um (right). n = 20
cells, mean ± SD.

6.4. CONCLUSIONS
Numerous engineered hydrogels have been used to investigate how biologically
and/or developmentally relevant cues can regulate cell behavior and fate. For
instance, the secretion of PCM proteins in the context of progenitor cell differentiation
is a topic of ongoing interest in which hydrogel cues are known to influence PCM
deposition, assembly, and subsequent tissue maturation.29,30,32-36 In general, the direct
interactions

that

these

cells

are

assumed

to

have

with

their

engineered

microenvironments are used to explain observed phenotypes or fates.10,32,36,37
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However, prior work has found that the cell-hydrogel interface is dynamic, and that
interactions with the nascent extracellular proteins that cells deposit into their
microenvironments can persistently influence cell behavior, how they sense their
microenvironment, and even determine their fate.31 It was hypothesized that nascent
proteins may accumulate until engineered cues are masked, negating their direct
influence on cell behavior after some time.10,36 This would mean that any cues
engineered into hydrogels may have a limited window of influence on cells, but this
consideration is often overlooked in the selection and incorporation of biochemical
cues into hydrogels.
Here, our results indicate that this may indeed occur, where the engineered hydrogel
interfaces that are presented to cells in 3D hydrogels can be physically displaced from
the cell surface as nascent PCM begins to be deposited and assembled not long after
encapsulation. We observed this displacement by adapting methods for nascent PCM
protein and glycan labeling to visualize the spatiotemporal deposition and distribution
of these different PCM components by cells, and then by examining the formation of
this PCM in the presence of bead markers that enable us to visualize the hydrogel.
The results lend us insights into the dynamic nature of this cell–hydrogel interface,
where we hypothesized that engineered cues may eventually become displaced from
the cell surface by competing signals produced by the cell itself. Here, we found that
although these cells produce PCM rich in both proteins and glycans, with deposits of
both components increasing over time, the extent and pattern of elaboration of each
of these components differs markedly. Specifically, the protein component generally
remains compact and dense near the cell surface, whereas the glycan ring extends
significantly further from the cell. In particular, the elaboration of secreted proteins
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correlates well with the displacement of the hydrogel from this important interface as
early as day 1 (Figure 6.4).
Although our data show how nascent PCM accumulation can physically separate the cell
from the hydrogel, how engineered cues such as cell-adhesive peptides34 influence the
secretion and assembly of this nascent matrix remains unknown. In addition, whereas
the hydrogels explored here are covalently crosslinked and largely elastic, additional gel
properties such as viscoelasticity and chemical/noncovalent crosslinking may have an
important influence on how this PCM is deposited, assembled, and elaborated over
time.30,31 A cell’s ability to synthesize, adhere to, and remodel its PCM plays an
important role as well, and this can vary widely among different cell types as well as by
donor species, age, in vitro passage conditions, disease state, and the composition of
the hydrogel itself.31,38-41 Whereas the juvenile bovine chondrocytes used here quickly
produced robust PCM, human adult cells likely exhibit a different spatiotemporal profile
of matrix synthesis and elaboration. In addition, the HA backbone used to generate the
macromers used here possesses affinity for cell-surface CD44 receptors,42 which may
help serve to tether and retain the gel network at the cell surface for a longer duration
than an inert scaffold would be able to. Further studies are needed to evaluate how the
cell-hydrogel interface evolves with cell types that are clinically relevant for tissue
engineering (e.g. human mesenchymal stromal cells, or MSCs) and with different
hydrogel

compositions

with

varied

potential

adhesion

(e.g.

adhesive

peptide

modifications or biologically inert materials such as PEG) to the cell surface.
An important limitation of the metabolic labeling agents used in these studies is that the
label is restricted to either methionine-containing proteins or to all mannose-containing
glycans. Although the proteins found in the cartilage-like matrix (i.e. collagen II and
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aggrecan core protein) that is produced by chondrocytes are relatively methioninepoor,30 it was still possible to label and visualize them under these conditions.
Meanwhile, some fraction of the mannose-containing glycans that a cell synthesizes is
expected to end up on N-glycosylated proteins (e.g. cell-surface-bound glycoproteins);
many proteins are glycosylated as such, and thus are technically visualized by ManNAz,
but the relative abundance of these is low compared to proteoglycans. Importantly, the
matrix glycosaminoglycans could indeed be visualized using this approach: the
distribution patterns of ManNAz-labeled glycans were mostly dispersed well beyond the
cell surface. Another limitation of these methods is that they label nonspecifically; in
order to elucidate what specific proteins or glycans are being deposited, additional
characterization can be performed.
Taken together, these findings highlight the potential differences in the spatial
distributions of protein and glycan components of the nascent PCM in hydrogels, and
they suggest that cellular interactions with the biochemical signals that are often
engineered into hydrogels can be altered over time due to nascent matrix deposition that
displaces the gel from the cell surface. This may help explain why the influence of some
engineered cues, such as in hydrogels functionalized with covalently bound peptides,
appear to be restricted to earlier timepoints in these systems.10,36 These findings may
help inform the design of biochemical cues in hydrogels in favor of signals that are
biologically and/or developmentally relevant to the window of opportunity that
corresponds to these changes at the interface.
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CHAPTER 7
CONCLUSIONS, LIMITATIONS, AND FUTURE DIRECTIONS

7.1. OVERVIEW
The work presented in this dissertation investigates the interface between cells
and engineered hydrogels towards the engineering of cartilage tissue. As outlined in
Chapter 1, the clinical landscape for cartilage repair and limitations in current cartilage
repair approaches has spurred the development of cartilage tissue engineering
approaches.

Many of these approaches utilize cell-laden hydrogels, and the

consideration of important biological signals during cartilage development and
homeostasis can inform the design of improved tissue engineering strategies.1,2 As
described in Chapter 3, a number of emerging advances in hydrogel design for cartilage
tissue engineering applications have sought to incorporate such biologically relevant
signals to influence cell behavior. This thesis expands upon the application of cell-laden
hyaluronic acid (HA)-based hydrogels in this context by exploring the influence of the
extent and timing of the presentation of critical early developmental cues in the context
of chondrogenesis.
Chapter 4 investigated the interactions of cells with the base polymer (i.e., HA) that is
used to fabricate hydrogels. Specifically, this work described how the extent and type of
HA modification influences interactions with the important cell-surface receptor CD44, as
well as the downstream consequences for mesenchymal stromal cell (MSC)
chondrogenesis in hydrogels fabricated using modified HA. Chapter 5 focused on critical
cell-cell interaction cues that are present in cartilage development but typically absent in
hydrogels by incorporating N-Cadherin mimetic peptides with varied dosing and timing
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and then characterizing their influence on MSC chondrogenesis. Chapter 6
characterized the elaboration of pericellular matrix (PCM) at the cell-hydrogel interface
by cells themselves, which occurs early in chondrogenesis and may inform our
understanding of the timing of engineered cues presented to cells in hydrogels. The
remainder of this chapter will highlight the main conclusions, limitations, and future
directions relevant to each of these aims.

7.2. SPECIFIC AIM 1
PROBE THE INFLUENCE OF HA MODIFICATION ON CD44-MEDIATED MSC
INTERACTIONS WITH HA HYDROGELS.

7.2.1. CONCLUSIONS
In this aim, we describe how chemical modifications that are made to HA, which
are used to then crosslink HA into hydrogels, can in fact alter HA-CD44 interactions.
Using a variety of interaction and adhesion assays (e.g., HA binding to CD44 coated
surfaces, HA binding to CD44-presenting cells, CD44 bead adhesion to HA hydrogels,
cellular responses when embedded in HA hydrogels), we determined that this depends
on three parameters: the extent of modification, the type of modification added, and the
site on the HA backbone that is modified. In general, a more hydrophobic pendant group
attached to a more critical site for CD44 binding (e.g., the charged carboxylic acid) on
the HA backbone exhibited marked effects on these interactions. The effects of the
degree of modification were observed first by measuring the binding avidity of modified
HA to either immobilized CD44 or to the surface of MSCs, and then we assayed the
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effects of HA modification of HA-CD44 adhesion when this modified HA is crosslinked
into hydrogels. Importantly, HA hydrogels containing moderately (here, ~20%) modified
macromers still promoted greater binding to CD44 relative to inert molecules, and they
also upregulated chondrogenesis and cartilage formation in HA hydrogels when
compared to inert PEG hydrogel controls. However, higher modifications (e.g., ~40%) on
the carboxylic acid led to outcomes of binding and down-stream cellular responses that
were similar to that of inert PEG hydrogels. These findings indicate the importance of
understanding how these modifications to HA influence cell behavior when used as
biomaterials that interact with cells and may point to the importance to understanding
modifications to biopolymers in general.

7.2.2. LIMITATIONS AND FUTURE DIRECTIONS
The HA-CD44 interactions described in this chapter lay the groundwork for a
much wider variety of modifications to be tested for their ability to preserve this important
and biologically relevant interaction. Here, the studies were confined to two pendant
groups, two sites on the HA backbone, and three extents of modification, but a brief
survey of the field quickly reveals that the variations on these three parameters that have
been incorporated and tested in hydrogels for biomedical applications are far more
extensive and ongoing.3,4 In our studies, norbornene was selected as a bulky
hydrophobic pendant that may be expected to alter this interaction, whereas
methacrylate was selected as a well-characterized pendant group that was expected to
have less of an effect; these effects on CD44-HA interactions, however, may in fact be
more pronounced with even larger and/or more hydrophobic pendant groups or further
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attenuated with more hydrophilic ones.5 Screens that assay engineered HA-based
materials for their ability to effectively bind CD44 may aid in material design.
The HA hydrogels investigated in this study were fairly stable in these cultures;
however, the degradation of HA hydrogels may influence how a cell responds to these
signals at a dynamic interface. For example, cells invading into a hydrogel may change
how their receptors interact with HA. Additionally, we limited this study to CD44, as this
is the primary receptor that is often implicated in biological activity in HA. However,
other receptors are important as well, such as CD168, which is implicated in motility and
signaling. There may be secondary interactions playing a role in our findings as well, as
other proteins and biomolecules can also bind to HA that may influence cell interactions
beyond only CD44.
We suggest that these aspects of macromer design should be considered in the
design of HA hydrogels for tissue engineering applications, but the biological relevance
and role of HA interactions with CD44 is in fact highly cell-, tissue-, and disease statedependent due at least in part to wide variation in CD44 isomer expression.6 Evaluation
of this relevance in a variety of biological contexts is necessary to determine where this
interaction must be preserved and prioritized, and while the studies here focused on
characterizing these interactions in vitro, their ultimate relevance in vivo needs to be
determined as well. In applications where this interaction proves to be biologically
relevant, additional work can focus on engineering materials that minimize the effects of
modification, whether by identifying pendant groups that best preserve the interaction or
by developing strategies to reliably incorporate and present unmodified HA as a cue in
these systems.
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7.3. SPECIFIC AIM 2
INVESTIGATE THE ROLE OF THE MAGNITUDE AND TIMING OF N-CADHERIN
SIGNALS TO MSCS WITHIN HA HYDROGELS TOWARD CHONDROGENESIS

7.3.1. CONCLUSIONS
In this aim, we demonstrated that the mimicry of N-Cadherin-mediated binding
between cells that is essential to normal cartilage development can be achieved using
tethered N-Cadherin mimetic peptides that both enhance the early expression of
chondrogenic markers and promote long-term cartilage matrix production in HA
hydrogels in a strong dose-dependent fashion. In particular, stably presented mimetic
peptides exerted their influence on chondrogenic gene expression mainly at early
timepoints up to 7 days, although this seems to be sufficient to drive enhanced matrix
elaboration up to 8 weeks. Furthermore, we found that the duration of presentation
appears to be critical to these effects, such that highly transient peptides (engineered to
degrade in response to ADAM10, a protease that regulates N-cadherin expression in
cells) with the same NCad mimetic moiety do not exert the same influence on MSC
chondrogenesis and downstream matrix formation. Meanwhile, when we controlled the
cleavage of this transient peptide signal via protease inhibition, this inhibition of mimetic
peptide cleavage enhanced the outcomes measured, further reinforcing the importance
of the duration of presentation. Overall, this work identifies the importance of temporal
design on the inclusion of biological signals into engineered hydrogels, which should be
considered in material design for tissue engineering.
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7.3.2. LIMITATIONS AND FUTURE DIRECTIONS
The dose dependence and timing dependence of N-Cadherin mimetic peptide
cues in hydrogels for cartilage tissue engineering underscore the potential for nuanced
material design to guide differentiation by providing biochemical signals that reflect the
nuances of the cell microenvironment in tissue development. However, one limitation of
these studies is that there is no optimization of dosing or additional control of timing. The
highest concentration of peptide incorporated in these studies was limited by the
solubility of the peptide cue, and this would need to be addressed with further studies of
the peptide design to permit the incorporation of higher densities of signal in our
hydrogels. Meanwhile, the ADAM10-cleavable peptide design employed here permitted
rapid local removal of the peptide signal from the hydrogel by each cell, but since this
particular sequence seems to be so efficiently cleaved that it abrogates the effect of the
signal almost entirely, new iterations of this type of peptide may need to consider
cleavable sequences that are less efficiently or more selectively cleaved.
One approach that may be useful to explore the large parameter space of such
engineered hydrogel signals is high-throughput screening techniques.

During my

dissertation studies I was involved in the development of such a technique to screen
encapsulated cell response to variations in peptide (e.g., RGD, HAV) concentrations.
Techniques such as this will help to understand how peptide concentrations, as well as
the synergy between peptides influence cell behavior.

As part of this work, MSC

chondrogenesis was explored and then scale to discrete hydrogels to show that the
screening approach translates to individual constructs. In the future, such techniques
can be expanded even further to accelerate our understanding of biochemical and
biomechanical signals in 3D hydrogels on encapsulated cell behavior.
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Towards understanding of cell interactions with N-cadherin, there are also a
number of additional spatial considerations that were not studied here but are believed
to be important for signaling: at the single-protein scale, for instance, dimerization may
play a role in the mimicry of N-Cadherin interactions and determine how effectively this
signal is transduced. N-Cadherins on the cell surface form dimers for proper signal
transduction, and, accordingly, cyclic tandem repeat-containing peptides have been
reported to exert greater agonist activity,7 but this type of peptide was not included in the
studies performed here. Additionally, the spatial clustering of numerous mimetic peptides
in the hydrogel microenvironment to encourage adherens junction formation and stability
may also need to be designed to enhance peptide-cell interactions and downstream cell
signaling, as this stable cluster formation is important in cadherin signaling.8 Looking
forward, the principles for nuanced material design that are explored in this aim may be
applicable for other biochemical cues as well: parameters such as the variations in
peptide design, dosing, and duration of presentation could be used to establish similar
dose dependence and nuanced presentation for other cues.
Notably, all of these studies were performed in vitro, and while prior work has
established that this mimetic peptide exerts pro-chondrogenic effects in in vivo settings
as well,9 additional studies need to be done in an in vivo setting that is clinically relevant
for cartilage repair to better understand the utility of these types of signals for cartilage
tissue engineering.
Finally, even the stably presented peptides that were used in these studies
appear to exert their effects mostly at early timepoints, and these temporal studies of the
N-Cadherin mimetic peptides raise a question of whether cells may, in fact, be able to
self-regulate their experience of their microenvironment in such systems via their
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deposition of matrix as chondrogenesis proceeds. Such matrix deposition could
effectively mimic the essential transition from cell-cell to cell-ECM interactions during
development and thus, in certain contexts, obviate the need to engineer interventions to
regulate the presentation of cues. This in fact motivated the studies conducted in Aim 3
of this thesis.

7.4. SPECIFIC AIM 3
INVESTIGATE THE DEPOSITION OF PERICELLULAR MATRIX BY CELLS WITHIN
HA HYDROGELS USING METABOLIC LABELING TECHNIQUES

7.4.1. CONCLUSIONS
In this aim, we demonstrated the deposition and distribution of pericellular matrix (PCM)
by cells in 3D hydrogels and how this early PCM deposition alters the way cells
experience the cell-hydrogel interface over time. We adapted metabolic labeling
techniques to identify important differences in the spatial distributions of early protein
and glycan components of the nascent PCM in HA hydrogels, and we also found that
cellular interactions with the hydrogel environment may only persist for a limited time
before their own PCM deposition displaces the hydrogel from the cell surface—here, in
as few as 3 days. The displacement of the hydrogel is robust and independent of
hydrogel properties such as crosslink density or macromer concentration, such that the
hydrogel was displaced from the cell surface ~1 µm in every hydrogel tested by day 7 of
culture. This agrees well with prior findings that the influence of some engineered cues,
such as in hydrogels functionalized with covalently bound peptides like the N-Cadherin
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mimetic peptides described in Aim 2, appear to be restricted to earlier timepoints in
these systems.9,10 Overall, these findings are quite important as they indicated that an
understanding of not only the initial cell-hydrogel interface is important, but also how this
interface changes over time based on deposited matrix.

7.4.2. LIMITATIONS AND FUTURE DIRECTIONS
In this aim, we demonstrated that the engineered hydrogels that we present to
cells in 3D can be physically displaced from the cell surface as cells begin to deposit and
assemble nascent PCM soon after encapsulation, but a number of limitations to these
studies pertain to the properties of the hydrogels and cells that were used. The hydrogel
formulations explored here are covalently crosslinked and largely elastic and limited to
only a few compositions, and additional gel properties such as viscoelasticity and
chemical/noncovalent crosslinking may influence how PCM is deposited, assembled,
and elaborated over time.11,12 In addition, engineered cues such as peptides9 that are
tethered to the base material can influence the secretion and assembly of this nascent
matrix, but the finer aspects of these effects remain largely unknown, and these types of
engineered cues were not explored here. Meanwhile, the HA used here possesses
some affinity for cell-surface CD44 receptors,13 which may in fact help serve to tether
and retain the gel at the cell surface for a longer duration than an inert scaffold would be
able to. Future work will need to consider these additional gel properties and how they
can influence the deposition and distribution of PCM.
As for the cell type used, the cell’s ability to synthesize, adhere to, and remodel
its PCM can vary widely among different cell types as well as by species, age, passage
conditions, disease state, and even the composition and design of the hydrogel
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itself.12,14-17 For the purposes of the questions at hand, we selected primary juvenile
bovine chondrocytes for their ability to synthesize a uniform and robust PCM, but this
cell type is not clinically relevant. Future work may address how this cell-hydrogel
interface evolves for cell types with various capacities for matrix production, such as the
MSCs used in other Aims. We expect that the rate of PCM deposition and heterogeneity
across cells may vary based on the cells investigated.
Finally, a limitation of the metabolic labeling strategy employed in our studies is
that the label is not specific to particular proteins or glycans of interest (e.g. collagen or
sulfated glycosaminoglycans), but they are simultaneously restricted to proteins that
contain methionine or glycans that contain mannose, respectively.11,18 Additional studies
may help elucidate the specific composition of the labeled PCM, probe for any
components that may be present but are methionine- or mannose-poor, and provide
further insight into the spatial deposition of specific matrix components over time. As an
example, the labeled proteins and glycans can also be stained for molecules of interest
(Figure 7.1) or techniques such as proteomics can be used to better understand which
proteins are being deposited in the PCM.
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Figure 7.1. Staining of PCM to identify specific matrix components. Bovine
chondrocytes incubated in hydrogels in vitro in labeling media for 7 days and then
double stained for nascent matrix using DBCO dye as well as antibodies for collagen
type II, collagen type VI, and chondroitin sulfate reveal that these proteins colocalize with
the metabolically labeled PCM.

7.5. OVERALL SUMMARY
Overall, the broad conclusions of this dissertation serve to inform the design of cell-laden
HA hydrogels for cartilage engineering through the exploration of critical early cues in
the context of chondrogenesis. We evaluated these parameters using innovative
techniques and in vitro models that enabled observation of both early differentiation and
bulk construct maturation in these systems. We also characterized the dynamic cell
interactions with the hydrogel that can happen over time at single-cell resolution to better
understand what happens at the cell-hydrogel interface at critical early timepoints. As
our understanding of this important interface and the presentation of cues continues to
evolve, studies such as the ones described in this thesis will form the basis for novel
material designs for cartilage repair.
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